{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:44:43Z","timestamp":1792201483045,"version":"4.4.0"},"reference-count":745,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":488,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1124\/pharmrev.122.000600","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T13:31:16Z","timestamp":1683725476000},"page":"885-958","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":187,"title":["Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3990-2963","authenticated-orcid":false,"given":"Mauro","family":"Maccarrone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Di Marzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrg","family":"Gertsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Grether","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allyn C.","family":"Howlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Makriyannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Piomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuo","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"van der Stelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/pharmrev.122.000600_bib1","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/cpt.108","article-title":"Cannabis in cancer care","volume":"97","author":"Abrams","year":"2015","journal-title":"Clin Pharmacol ther"},{"key":"10.1124\/pharmrev.122.000600_bib2","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1021\/ja01182a068","article-title":"Tetrahydrocannabinol homologs with double branched alkyl groups in the 3-position","volume":"70","author":"Adams","year":"1948","journal-title":"J Am Chem Soc"},{"key":"10.1124\/pharmrev.122.000600_bib3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cmet.2007.11.012","article-title":"The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake","volume":"7","author":"Addy","year":"2008","journal-title":"Cell Metab"},{"key":"10.1124\/pharmrev.122.000600_bib4","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1021\/acs.chemrev.5b00411","article-title":"Medicinal chemistry, pharmacology, and potential therapeutic benefits of cannabinoid CB2 receptor agonists","volume":"116","author":"Aghazadeh Tabrizi","year":"2016","journal-title":"Chem Rev"},{"key":"10.1124\/pharmrev.122.000600_bib5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4161\/19490976.2014.990790","article-title":"Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice","volume":"6","author":"Aguilera","year":"2015","journal-title":"Gut Microbes"},{"key":"10.1124\/pharmrev.122.000600_bib6","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s11307-013-0626-y","article-title":"Whole-body biodistribution and radiation dosimetry of the cannabinoid type 2 receptor ligand [11C]-NE40 in healthy subjects","volume":"15","author":"Ahmad","year":"2013","journal-title":"Mol Imaging Biol"},{"key":"10.1124\/pharmrev.122.000600_bib7","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1007\/s00259-016-3457-7","article-title":"Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer\u2019s disease","volume":"43","author":"Ahmad","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1124\/pharmrev.122.000600_bib8","doi-asserted-by":"crossref","first-page":"13019","DOI":"10.1021\/bi701378g","article-title":"Novel mechanistic class of fatty acid amide hydrolase inhibitors with remarkable selectivity","volume":"46","author":"Ahn","year":"2007","journal-title":"Biochemistry"},{"key":"10.1124\/pharmrev.122.000600_bib9","doi-asserted-by":"crossref","first-page":"9699","DOI":"10.1021\/ja062999h","article-title":"The putative endocannabinoid transport blocker LY2183240 is a potent inhibitor of FAAH and several other brain serine hydrolases","volume":"128","author":"Alexander","year":"2006","journal-title":"J Am Chem Soc"},{"key":"10.1124\/pharmrev.122.000600_bib10","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1096\/fj.14-255208","article-title":"N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis","volume":"29","author":"Alhouayek","year":"2015","journal-title":"FASEB J"},{"key":"10.1124\/pharmrev.122.000600_bib11","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.tips.2018.02.011","article-title":"Lysophosphatidylinositols, from cell membrane constituents to GPR55 ligands","volume":"39","author":"Alhouayek","year":"2018","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/pharmrev.122.000600_bib12","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.3390\/ijms20081837","article-title":"Structural insights into CB1 receptor biased signaling","volume":"20","author":"Al-Zoubi","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.122.000600_bib13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/13543776.2019.1597851","article-title":"A patent update on cannabinoid receptor 1 antagonists (2015-2018)","volume":"29","author":"Amato","year":"2019","journal-title":"Expert Opin Ther Pat"},{"key":"10.1124\/pharmrev.122.000600_bib14","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1021\/acs.jmedchem.7b01820","article-title":"Blocking alcoholic steatosis in mice with a peripherally restricted purine antagonist of the type 1 cannabinoid receptor","volume":"61","author":"Amato","year":"2018","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-3-030-21737-2_8","article-title":"Pharmacology of medical cannabis","volume":"1162","author":"Amin","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"10.1124\/pharmrev.122.000600_bib16","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.protis.2009.12.004","article-title":"Identification of endocannabinoids and related N-acylethanolamines in tetrahymena. A new class of compounds for Tetrahymena","volume":"161","author":"Anagnostopoulos","year":"2010","journal-title":"Protist"},{"key":"10.1124\/pharmrev.122.000600_bib17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.brainresrev.2008.12.003","article-title":"Targeting CB2 receptors and the endocannabinoid system for the treatment of pain","volume":"60","author":"Anand","year":"2009","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1124\/pharmrev.122.000600_bib18","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1021\/jo00433a020","article-title":"Cannabinoids. 3. Synthetic approaches to 9-ketocannabinoids. Total synthesis of nabilone","volume":"42","author":"Archer","year":"1977","journal-title":"J Org Chem"},{"key":"10.1124\/pharmrev.122.000600_bib19","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/s41467-021-20946-6","article-title":"Anti-inflammatory dopamine- and serotonin-based endocannabinoid epoxides reciprocally regulate cannabinoid receptors and the TRPV1 channel","volume":"12","author":"Arnold","year":"2021","journal-title":"Nat Commun"},{"key":"10.1124\/pharmrev.122.000600_bib20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1476-5381.2010.00729.x","article-title":"CB2: a cannabinoid receptor with an identity crisis","volume":"160","author":"Atwood","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib21","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1124\/mol.111.074013","article-title":"Functional selectivity in CB(2) cannabinoid receptor signaling and regulation: implications for the therapeutic potential of CB(2) ligands","volume":"81","author":"Atwood","year":"2012","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib22","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/978-1-0716-2728-0_39","article-title":"Machine learning and computational chemistry for the endocannabinoid system","volume":"2576","author":"Atz","year":"2023","journal-title":"Methods Mol Biol"},{"key":"10.1124\/pharmrev.122.000600_bib23","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1007\/s00213-020-05570-4","article-title":"Oleoyl alanine (HU595): a stable monomethylated oleoyl glycine interferes with acute naloxone precipitated morphine withdrawal in male rats","volume":"237","author":"Ayoub","year":"2020","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.122.000600_bib24","doi-asserted-by":"crossref","first-page":"8851","DOI":"10.1021\/jacs.5b04883","article-title":"Highly selective, reversible inhibitor identified by comparative chemoproteomics modulates diacylglycerol lipase activity in neurons","volume":"137","author":"Baggelaar","year":"2015","journal-title":"J Am Chem Soc"},{"key":"10.1124\/pharmrev.122.000600_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2018.05.002","article-title":"2-Arachidonoylglycerol: a signaling lipid with manifold actions in the brain","volume":"71","author":"Baggelaar","year":"2018","journal-title":"Prog Lipid Res"},{"key":"10.1124\/pharmrev.122.000600_bib26","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1021\/acschembio.6b01052","article-title":"Chemical proteomics maps brain region specific activity of endocannabinoid hydrolases","volume":"12","author":"Baggelaar","year":"2017","journal-title":"ACS Chem Biol"},{"key":"10.1124\/pharmrev.122.000600_bib27","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1093\/brain\/awac223","article-title":"Endocannabinoid dysfunction in neurological disease: neuro-ocular DAGLA-related syndrome","volume":"145","author":"Bainbridge","year":"2022","journal-title":"Brain"},{"key":"10.1124\/pharmrev.122.000600_bib28","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.phrs.2017.02.022","article-title":"The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABAA receptors","volume":"119","author":"Bakas","year":"2017","journal-title":"Pharmacol Res"},{"key":"10.1124\/pharmrev.122.000600_bib29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neuropharm.2017.10.040","article-title":"Cannabinoid-1 receptor neutral antagonist reduces binge-like alcohol consumption and alcohol-induced accumbal dopaminergic signaling","volume":"131","author":"Balla","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1124\/pharmrev.122.000600_bib30","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.jchromb.2009.04.010","article-title":"Development and validation of a quantitative method for the determination of 12 endocannabinoids and related compounds in human plasma using liquid chromatography-tandem mass spectrometry","volume":"877","author":"Balvers","year":"2009","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1124\/pharmrev.122.000600_bib31","doi-asserted-by":"crossref","first-page":"12212","DOI":"10.1074\/jbc.M411642200","article-title":"Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis","volume":"280","author":"Bari","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000600_bib32","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/cmdc.201900390","article-title":"Total synthesis of the endocannabinoid uptake inhibitor guineensine and SAR studies","volume":"14","author":"Bartholom\u00e4us","year":"2019","journal-title":"ChemMedChem"},{"key":"10.1124\/pharmrev.122.000600_bib33","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.bmcl.2014.12.031","article-title":"Selective CB2 receptor agonists. Part 3: the optimization of a piperidine-based series that demonstrated efficacy in an in vivo neuropathic pain model","volume":"25","author":"Bartolozzi","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pharmrev.122.000600_bib34","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1111\/bph.14495","article-title":"Reversal of albuminuria by combined AM6545 and perindopril therapy in experimental diabetic nephropathy","volume":"175","author":"Barutta","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib35","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/ndt\/gfx010","article-title":"Dual therapy targeting the endocannabinoid system prevents experimental diabetic nephropathy","volume":"32","author":"Barutta","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1124\/pharmrev.122.000600_bib36","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/cmdc.202000298","article-title":"Functionalized cannabinoid subtype 2 receptor ligands: fluorescent, PET, photochromic and covalent molecular probes","volume":"15","author":"Basagni","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1124\/pharmrev.122.000600_bib37","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/nmo.13148","article-title":"Targeting fatty acid amide hydrolase and transient receptor potential vanilloid-1 simultaneously to modulate colonic motility and visceral sensation in the mouse: a pharmacological intervention with N-arachidonoyl-serotonin (AA-5-HT)","volume":"29","author":"Bashashati","year":"2017","journal-title":"Neurogastroenterol Motil"},{"key":"10.1124\/pharmrev.122.000600_bib38","doi-asserted-by":"crossref","DOI":"10.1186\/1476-511X-1-1","article-title":"Anandamide uptake by synaptosomes from human, mouse and rat brain: inhibition by glutamine and glutamate","volume":"1","author":"Battista","year":"2002","journal-title":"Lipids Health Dis"},{"key":"10.1124\/pharmrev.122.000600_bib40","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.149","article-title":"Do N-arachidonyl-glycine (NA-glycine) and 2-arachidonoyl glycerol (2-AG) share mode of action and the binding site on the \u03b22 subunit of GABAA receptors?","volume":"1","author":"Baur","year":"2013","journal-title":"PeerJ"},{"key":"10.1124\/pharmrev.122.000600_bib41","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1021\/jm00107a034","article-title":"Antinociceptive (aminoalkyl)indoles","volume":"34","author":"Bell","year":"1991","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib42","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0014-2999(98)00821-8","article-title":"Anandamide transport inhibition by the vanilloid agonist olvanil","volume":"364","author":"Beltramo","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib43","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1126\/science.277.5329.1094","article-title":"Functional role of high-affinity anandamide transport, as revealed by selective inhibition","volume":"277","author":"Beltramo","year":"1997","journal-title":"Science"},{"key":"10.1124\/pharmrev.122.000600_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050968","article-title":"Targeting fatty acid binding protein (FABP) anandamide transporters - a novel strategy for development of anti-inflammatory and anti-nociceptive drugs","volume":"7","author":"Berger","year":"2012","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.122.000600_bib47","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/00498258009033728","article-title":"The stereoselective enzymic reduction of the synthetic 9-ketocannabinoid, nabilone, in vivo, in isolated liver cells and in liver homogenate","volume":"10","author":"Billings","year":"1980","journal-title":"Xenobiotica"},{"key":"10.1124\/pharmrev.122.000600_bib48","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.tips.2009.05.004","article-title":"The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities","volume":"30","author":"B\u00edr\u00f3","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/pharmrev.122.000600_bib49","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib50","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1083\/jcb.200305129","article-title":"Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain","volume":"163","author":"Bisogno","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1124\/pharmrev.122.000600_bib51","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/bph.12013","article-title":"A novel fluorophosphonate inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol with potential anti-obesity effects","volume":"169","author":"Bisogno","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib52","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1124\/pr.112.006387","article-title":"Chemical probes of endocannabinoid metabolism","volume":"65","author":"Blankman","year":"2013","journal-title":"Pharmacol Rev"},{"key":"10.1124\/pharmrev.122.000600_bib53","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.chembiol.2007.11.006","article-title":"A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol","volume":"14","author":"Blankman","year":"2007","journal-title":"Chem Biol"},{"key":"10.1124\/pharmrev.122.000600_bib54","doi-asserted-by":"crossref","first-page":"14782","DOI":"10.1038\/ncomms14782","article-title":"Endocannabinoid signalling modulates susceptibility to traumatic stress exposure","volume":"8","author":"Bluett","year":"2017","journal-title":"Nat Commun"},{"key":"10.1124\/pharmrev.122.000600_bib55","doi-asserted-by":"crossref","first-page":"9241","DOI":"10.1038\/s41598-022-13284-0","article-title":"FABP5 deletion in nociceptors augments endocannabinoid signaling and suppresses TRPV1 sensitization and inflammatory pain","volume":"12","author":"Bogdan","year":"2022","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.122.000600_bib56","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tips.2005.12.007","article-title":"Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery","volume":"27","author":"Bond","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/pharmrev.122.000600_bib57","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1124\/jpet.115.230516","article-title":"An important role for N-acylethanolamine acid amidase in the complete Freund\u2019s adjuvant rat model of arthritis","volume":"356","author":"Bonezzi","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.122.000600_bib58","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/13543776.2021.1841166","article-title":"An updated patent review of monoacylglycerol lipase (MAGL) inhibitors (2018-present)","volume":"31","author":"Bononi","year":"2021","journal-title":"Expert Opin Ther Pat"},{"key":"10.1124\/pharmrev.122.000600_bib59","doi-asserted-by":"crossref","first-page":"35450","DOI":"10.1074\/jbc.M109.006338","article-title":"Cannabinoid receptor type 1- and 2-mediated increase in cyclic AMP inhibits T cell receptor-triggered signaling","volume":"284","author":"B\u00f6rner","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000600_bib60","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.biopsych.2006.12.001","article-title":"Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress","volume":"62","author":"Bortolato","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pharmrev.122.000600_bib61","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1432-1033.1993.tb17910.x","article-title":"Cannabinoid-receptor expression in human leukocytes","volume":"214","author":"Bouaboula","year":"1993","journal-title":"Eur J Biochem"},{"key":"10.1124\/pharmrev.122.000600_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2017.04.001","article-title":"Oleic acid-derived oleoylethanolamide: a nutritional science perspective","volume":"67","author":"Bowen","year":"2017","journal-title":"Prog Lipid Res"},{"key":"10.1124\/pharmrev.122.000600_bib63","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1073\/pnas.1421420112","article-title":"A peripheral endocannabinoid mechanism contributes to glucocorticoid-mediated metabolic syndrome","volume":"112","author":"Bowles","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000600_bib64","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1126\/science.1076535","article-title":"Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling","volume":"298","author":"Bracey","year":"2002","journal-title":"Science"},{"key":"10.1124\/pharmrev.122.000600_bib65","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1021\/bi500632a","article-title":"Differential activation of intracellular versus plasmalemmal CB2 cannabinoid receptors","volume":"53","author":"Brailoiu","year":"2014","journal-title":"Biochemistry"},{"key":"10.1124\/pharmrev.122.000600_bib66","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4155\/ppa-2021-0002","article-title":"Cannabinoid receptor type 2 ligands: an analysis of granted patents since 2010","volume":"10","author":"Brennecke","year":"2021","journal-title":"Pharm Pat Anal"},{"key":"10.1124\/pharmrev.122.000600_bib67","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.tips.2015.08.010","article-title":"Polypharmacology shakes hands with complex aetiopathology","volume":"36","author":"Brodie","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/pharmrev.122.000600_bib68","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1093\/carcin\/bgq151","article-title":"Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines","volume":"31","author":"Brown","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1124\/pharmrev.122.000600_bib69","doi-asserted-by":"crossref","first-page":"102024","DOI":"10.1016\/j.plefa.2019.102024","article-title":"Anticancer effects of n-3 EPA and DHA and their endocannabinoid derivatives on breast cancer cell growth and invasion","volume":"156","author":"Brown","year":"2020","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1124\/pharmrev.122.000600_bib70","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1038\/s41598-017-02414-8","article-title":"Prostaglandin E2 glyceryl ester is an endogenous agonist of the nucleotide receptor P2Y6","volume":"7","author":"Br\u00fcser","year":"2017","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.122.000600_bib71","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1021\/ml400435h","article-title":"Functionally optimized neuritogenic farinosone C analogs: SAR r-study and investigations on their mode of action","volume":"5","author":"Burch","year":"2013","journal-title":"ACS Med Chem Lett"},{"key":"10.1124\/pharmrev.122.000600_bib72","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2174\/187153008785700118","article-title":"Cannabinoids as therapeutic agents for ablating neuroinflammatory disease","volume":"8","author":"Cabral","year":"2008","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1124\/pharmrev.122.000600_bib73","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/sj.bjp.0707584","article-title":"CB2 receptors in the brain: role in central immune function","volume":"153","author":"Cabral","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib74","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1523\/JNEUROSCI.17-04-01226.1997","article-title":"Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain","volume":"17","author":"Cadas","year":"1997","journal-title":"J Neurosci"},{"key":"10.1124\/pharmrev.122.000600_bib75","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/28393","article-title":"Control of pain initiation by endogenous cannabinoids","volume":"394","author":"Calignano","year":"1998","journal-title":"Nature"},{"key":"10.1124\/pharmrev.122.000600_bib76","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3389\/fphar.2017.00269","article-title":"Plastic and neuroprotective mechanisms involved in the therapeutic effects of cannabidiol in psychiatric disorders","volume":"8","author":"Campos","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib77","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1098\/rstb.2011.0389","article-title":"Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders","volume":"367","author":"Campos","year":"2012","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1124\/pharmrev.122.000600_bib78","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1053\/j.gastro.2012.12.028","article-title":"Monoacylglycerol lipase controls endocannabinoid and eicosanoid signaling and hepatic injury in mice","volume":"144","author":"Cao","year":"2013","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1124\/pharmrev.122.000600_bib79","first-page":"417S","article-title":"Hypnotic and antiepileptic effects of cannabidiol","volume":"21","author":"Carlini","year":"1981","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib80","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-1-4939-3539-0_6","article-title":"The displacement binding assay using human cannabinoid CB2 receptor-transfected cells","volume":"1412","author":"Cascio","year":"2016","journal-title":"Methods Mol Biol"},{"key":"10.1124\/pharmrev.122.000600_bib81","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s11481-017-9744-7","article-title":"Regulation of cell surface CB2 receptor during human B cell activation and differentiation","volume":"12","author":"Castaneda","year":"2017","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib82","doi-asserted-by":"crossref","first-page":"15975","DOI":"10.1038\/s41598-020-72861-3","article-title":"Dietary fatty acid intake and gut microbiota determine circulating endocannabinoidome signaling beyond the effect of body fat","volume":"10","author":"Castonguay-Paradis","year":"2020","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.122.000600_bib83","doi-asserted-by":"crossref","first-page":"101019","DOI":"10.1016\/j.plipres.2019.101019","article-title":"The (endo)cannabinoid signaling in female reproduction: what are the latest advances?","volume":"77","author":"Cecconi","year":"2020","journal-title":"Prog Lipid Res"},{"key":"10.1124\/pharmrev.122.000600_bib84","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00210-013-0930-8","article-title":"Evaluation of the specificity of antibodies raised against cannabinoid receptor type 2 in the mouse retina","volume":"387","author":"C\u00e9cyre","year":"2014","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib85","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008688","article-title":"Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors","volume":"5","author":"Cencioni","year":"2010","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.122.000600_bib86","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.tips.2007.02.004","article-title":"The endocannabinoid system in targeting inflammatory neurodegenerative diseases","volume":"28","author":"Centonze","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/pharmrev.122.000600_bib87","doi-asserted-by":"crossref","first-page":"R2185","DOI":"10.1152\/ajpregu.00663.2007","article-title":"A neutral CB1 receptor antagonist reduces weight gain in rat","volume":"293","author":"Chambers","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/pharmrev.122.000600_bib88","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bmc.2018.11.043","article-title":"Fluorine-18 isotope labeling for positron emission tomography imaging. Direct evidence for DBPR211 as a peripherally restricted CB1 inverse agonist","volume":"27","author":"Chang","year":"2019","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib89","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41564-021-00887-y","article-title":"Gut-inhabiting Clostridia build human GPCR ligands by conjugating neurotransmitters with diet- and human-derived fatty acids","volume":"6","author":"Chang","year":"2021","journal-title":"Nat Microbiol"},{"key":"10.1124\/pharmrev.122.000600_bib90","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00424-014-1467-5","article-title":"Modulation of T-type calcium channels by bioactive lipids","volume":"466","author":"Chemin","year":"2014","journal-title":"Pflugers Arch"},{"key":"10.1124\/pharmrev.122.000600_bib91","doi-asserted-by":"crossref","first-page":"102279","DOI":"10.1016\/j.jbc.2022.102279","article-title":"G protein-coupled receptor interactions with arrestins and GPCR kinases: the unresolved issue of signal bias","volume":"298","author":"Chen","year":"2022","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000600_bib92","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.celrep.2012.09.030","article-title":"Monoacylglycerol lipase is a therapeutic target for Alzheimer\u2019s disease","volume":"2","author":"Chen","year":"2012","journal-title":"Cell Rep"},{"key":"10.1124\/pharmrev.122.000600_bib93","doi-asserted-by":"crossref","first-page":"34660","DOI":"10.1074\/jbc.M112.373241","article-title":"Evidence for bidirectional endocannabinoid transport across cell membranes","volume":"287","author":"Chicca","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000600_bib94","doi-asserted-by":"crossref","first-page":"E5006","DOI":"10.1073\/pnas.1704065114","article-title":"Chemical probes to potently and selectively inhibit endocannabinoid cellular reuptake","volume":"114","author":"Chicca","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000600_bib95","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.intimp.2009.03.006","article-title":"Synergistic immunomopharmacological effects of N-alkylamides in Echinacea purpurea herbal extracts","volume":"9","author":"Chicca","year":"2009","journal-title":"Int Immunopharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib96","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/S0140-6736(07)61721-8","article-title":"Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials","volume":"370","author":"Christensen","year":"2007","journal-title":"Lancet"},{"key":"10.1124\/pharmrev.122.000600_bib97","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-1-0716-2728-0_16","article-title":"Endocannabinoid metabolism and transport as drug targets","volume":"2576","author":"Ciaramellano","year":"2023","journal-title":"Methods Mol Biol"},{"key":"10.1124\/pharmrev.122.000600_bib98","doi-asserted-by":"crossref","first-page":"107477","DOI":"10.1016\/j.pharmthera.2020.107477","article-title":"The therapeutic potential of second and third generation CB1R antagonists","volume":"208","author":"Cinar","year":"2020","journal-title":"Pharmacol Ther"},{"key":"10.1124\/pharmrev.122.000600_bib99","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/nn.2632","article-title":"Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism","volume":"13","author":"Clapper","year":"2010","journal-title":"Nat Neurosci"},{"key":"10.1124\/pharmrev.122.000600_bib100","unstructured":"Clarivate (2022a) Drug report on ART-27.13. Cortellis data base, https:\/\/www.cortellis.com\/intelligence\/report\/ci\/nextgendrugall\/54930 (accessed October 2022)"},{"key":"10.1124\/pharmrev.122.000600_bib101","unstructured":"Clarivate (2022b) Drug report on cannabidiol. Cortellis data base, https:\/\/www.cortellis.com\/intelligence\/report\/ci\/nextgendrugall\/57457 (accessed October 2022)"},{"key":"10.1124\/pharmrev.122.000600_bib102","unstructured":"Clarivate (2022c) Drug report on CMX-020. Cortellis data base, https:\/\/www.cortellis.com\/intelligence\/report\/ci\/nextgendrugall\/89531 (accessed October 2022)"},{"key":"10.1124\/pharmrev.122.000600_bib104","unstructured":"Clarivate (2022d) Drug report on dronabinol. Cortellis data base, https:\/\/www.cortellis.com\/intelligence\/report\/ci\/nextgendrugall\/12866 (accessed October 2022)"},{"key":"10.1124\/pharmrev.122.000600_bib106","unstructured":"Clarivate (2022e) Drug report on KN 387271. Cortellis data base, https:\/\/www.cortellis.com\/intelligence\/report\/ci\/nextgendrugall\/22439 (accessed October 2022)"},{"key":"10.1124\/pharmrev.122.000600_bib107","unstructured":"Clarivate (2022f) Drug report on LY-2828360. Cortellis data base, https:\/\/www.cortellis.com\/intelligence\/report\/ci\/nextgendrugall\/70612 (accessed October 2022)"},{"key":"10.1124\/pharmrev.122.000600_bib108","unstructured":"Clarivate (2022g) Drug report on nabiximols. Cortellis data base, https:\/\/www.cortellis.com\/intelligence\/report\/ci\/nextgendrugall\/94779 (accessed October 2022)"},{"key":"10.1124\/pharmrev.122.000600_bib109","unstructured":"Clarivate (2022h) Drug report on NTRX-07. Cortellis data base, https:\/\/www.cortellis.com\/intelligence\/report\/ci\/nextgendrugall\/104592 (accessed October 2022)"},{"key":"10.1124\/pharmrev.122.000600_bib110","unstructured":"Clarivate (2022i) Drug report on olorinab. Cortellis data base, https:\/\/www.cortellis.com\/intelligence\/report\/ci\/nextgendrugall\/70435 (accessed October 2022)"},{"key":"10.1124\/pharmrev.122.000600_bib111","unstructured":"Clarivate (2022j) Drug report on PRS-211375. Cortellis data base, https:\/\/www.cortellis.com\/intelligence\/report\/ci\/nextgendrugall\/27212 (accessed October 2022)"},{"key":"10.1124\/pharmrev.122.000600_bib112","unstructured":"Clarivate (2022k) Drug report on RG7774. Cortellis data base, https:\/\/www.cortellis.com\/intelligence\/report\/ci\/nextgendrugall\/121857 (accessed October 2022)"},{"key":"10.1124\/pharmrev.122.000600_bib113","unstructured":"Clarivate (2022l) Drug report on S-777469. Cortellis data base, https:\/\/www.cortellis.com\/intelligence\/report\/ci\/nextgendrugall\/56044 (accessed October 2022)"},{"key":"10.1124\/pharmrev.122.000600_bib114","unstructured":"Clarivate (2022m) Drug report on TAK-937. Cortellis data base, https:\/\/www.cortellis.com\/intelligence\/report\/ci\/nextgendrugall\/63642 (accessed October 2022)"},{"key":"10.1124\/pharmrev.122.000600_bib115","unstructured":"Clarivate (2022n) Drug report on tedalinab. Cortellis data base, https:\/\/www.cortellis.com\/intelligence\/report\/ci\/nextgendrugall\/55827 (accessed October 2022)"},{"key":"10.1124\/pharmrev.122.000600_bib116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144270","article-title":"Prevention of diet-induced obesity effects on body weight and gut microbiota in mice treated chronically with \u03949-tetrahydrocannabinol","volume":"10","author":"Cluny","year":"2015","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.122.000600_bib117","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1476-5381.2010.00908.x","article-title":"A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents","volume":"161","author":"Cluny","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib118","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/cpt.1381","article-title":"Positive and negative effects of cannabis and cannabinoids on health","volume":"105","author":"Cohen","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pharmrev.122.000600_bib119","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nature23874","article-title":"Commensal bacteria make GPCR ligands that mimic human signalling molecules","volume":"549","author":"Cohen","year":"2017","journal-title":"Nature"},{"key":"10.1124\/pharmrev.122.000600_bib120","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0091-3057(91)90386-G","article-title":"Controlled clinical trial of cannabidiol in Huntington\u2019s disease","volume":"40","author":"Consroe","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pharmrev.122.000600_bib121","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/00207458608985678","article-title":"Open label evaluation of cannabidiol in dystonic movement disorders","volume":"30","author":"Consroe","year":"1986","journal-title":"Int J Neurosci"},{"key":"10.1124\/pharmrev.122.000600_bib122","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/pr.116.013243","article-title":"Chemical tools for studying lipid-binding class A G protein-coupled receptors","volume":"69","author":"Cooper","year":"2017","journal-title":"Pharmacol Rev"},{"key":"10.1124\/pharmrev.122.000600_bib123a","unstructured":"Corbus Pharmaceuticals (2022) Drug report on lenabasum. Adis Insight data base, https:\/\/adisinsight.springer.com\/drugs\/800007180"},{"key":"10.1124\/pharmrev.122.000600_bib123","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.bbi.2011.01.020","article-title":"The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70\/IL-23 axis and IL-10 in microglial cells","volume":"25","author":"Correa","year":"2011","journal-title":"Brain Behav Immun"},{"key":"10.1124\/pharmrev.122.000600_bib124","doi-asserted-by":"crossref","first-page":"9371","DOI":"10.1073\/pnas.161191698","article-title":"Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase","volume":"98","author":"Cravatt","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000600_bib125","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/384083a0","article-title":"Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides","volume":"384","author":"Cravatt","year":"1996","journal-title":"Nature"},{"key":"10.1124\/pharmrev.122.000600_bib127","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","article-title":"Cannabinoids and the expanded endocannabinoid system in neurological disorders","volume":"16","author":"Cristino","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"10.1124\/pharmrev.122.000600_bib128","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000137430","article-title":"Chronic administration of cannabidiol to healthy volunteers and epileptic patients","volume":"21","author":"Cunha","year":"1980","journal-title":"Pharmacology"},{"key":"10.1124\/pharmrev.122.000600_bib129","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3390\/biomedicines9040346","article-title":"Effects of chronic oral probiotic treatment in paclitaxel-induced neuropathic pain","volume":"9","author":"Cuozzo","year":"2021","journal-title":"Biomedicines"},{"key":"10.1124\/pharmrev.122.000600_bib130","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1042\/BJ20130960","article-title":"Membrane lipids are key modulators of the endocannabinoid-hydrolase FAAH","volume":"457","author":"Dainese","year":"2014","journal-title":"Biochem J"},{"key":"10.1124\/pharmrev.122.000600_bib131","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1038\/s41598-020-59120-1","article-title":"The endocannabinoid hydrolase FAAH is an allosteric enzyme","volume":"10","author":"Dainese","year":"2020","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.122.000600_bib132","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1021\/jm00079a016","article-title":"Conformationally restrained analogues of pravadoline: nanomolar potent, enantioselective, (aminoalkyl)indole agonists of the cannabinoid receptor","volume":"35","author":"D\u2019Ambra","year":"1992","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib133","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.bbagen.2019.01.002","article-title":"Identification and characterization of phytocannabinoids as novel dual PPAR\u03b1\/\u03b3 agonists by a computational and in vitro experimental approach","volume":"1863","author":"D\u2019Aniello","year":"2019","journal-title":"Biochim Biophys Acta, Gen Subj"},{"key":"10.1124\/pharmrev.122.000600_bib134","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/s41467-022-28609-w","article-title":"AP-4-mediated axonal transport controls endocannabinoid production in neurons","volume":"13","author":"Davies","year":"2022","journal-title":"Nat Commun"},{"key":"10.1124\/pharmrev.122.000600_bib135","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1124\/mol.59.6.1369","article-title":"Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamide","volume":"59","author":"Day","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib136","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.682","article-title":"Diversity of molecular targets and signaling pathways for CBD","volume":"8","author":"de Almeida","year":"2020","journal-title":"Pharmacol Res Perspect"},{"key":"10.1124\/pharmrev.122.000600_bib137","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.2174\/1381612820666140130212957","article-title":"Role of the endocannabinoid system in the neuroendocrine responses to inflammation","volume":"20","author":"De Laurentiis","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.1124\/pharmrev.122.000600_bib138","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0014-5793(00)02082-2","article-title":"Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity","volume":"483","author":"De Petrocellis","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1124\/pharmrev.122.000600_bib139","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/sj.bjp.0705666","article-title":"The endocannabinoid system: a general view and latest additions","volume":"141","author":"De Petrocellis","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib140","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1194\/jlr.M800337-JLR200","article-title":"Chemical synthesis, pharmacological characterization, and possible formation in unicellular fungi of 3-hydroxy-anandamide","volume":"50","author":"De Petrocellis","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1124\/pharmrev.122.000600_bib141","series-title":"The Endocannabinoidome: The World of Endocannabinoids and Related Mediators","first-page":"67","article-title":"N-Acyldopamines and N-acylserotonins: from synthetic pharmacological tools to endogenous multitarget mediators","author":"De Petrocellis","year":"2014"},{"key":"10.1124\/pharmrev.122.000600_bib142","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1476-5381.2010.01166.x","article-title":"Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes","volume":"163","author":"De Petrocellis","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib143","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1016\/j.yexcr.2007.05.012","article-title":"Mechanisms for the coupling of cannabinoid receptors to intracellular calcium mobilization in rat insulinoma beta-cells","volume":"313","author":"De Petrocellis","year":"2007","journal-title":"Exp Cell Res"},{"key":"10.1124\/pharmrev.122.000600_bib144","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0306-4522(98)00749-0","article-title":"Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response","volume":"92","author":"De Petrocellis","year":"1999","journal-title":"Neuroscience"},{"key":"10.1124\/pharmrev.122.000600_bib145","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1748-1716.2011.02338.x","article-title":"Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation","volume":"204","author":"De Petrocellis","year":"2012","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1124\/pharmrev.122.000600_bib146","doi-asserted-by":"crossref","first-page":"21703","DOI":"10.1038\/srep21703","article-title":"The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-\u03b3 and CB2 pathways","volume":"6","author":"del R\u00edo","year":"2016","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.122.000600_bib147","first-page":"269","article-title":"Attenuation of cocaine-induced conditioned place preference and motor activity via cannabinoid CB2 receptor agonism and CB1 receptor antagonism in rats","volume":"20","author":"Delis","year":"2017","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib148","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.apsb.2019.10.006","article-title":"Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders","volume":"10","author":"Deng","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1124\/pharmrev.122.000600_bib149","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1021\/acs.jmedchem.6b01482","article-title":"Triazole ureas act as diacylglycerol lipase inhibitors and prevent fasting-induced refeeding","volume":"60","author":"Deng","year":"2017","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib150","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s41591-019-0495-2","article-title":"Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study","volume":"25","author":"Depommier","year":"2019","journal-title":"Nat Med"},{"key":"10.1124\/pharmrev.122.000600_bib151","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3390\/cells10010185","article-title":"Beneficial effects of Akkermansia muciniphila are not associated with major changes in the circulating endocannabinoidome but linked to higher mono-palmitoyl-glycerol levels as new PPAR\u03b1 agonists","volume":"10","author":"Depommier","year":"2021","journal-title":"Cells"},{"key":"10.1124\/pharmrev.122.000600_bib152","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.1074\/jbc.270.11.6030","article-title":"Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization","volume":"270","author":"Desarnaud","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000600_bib153","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa044537","article-title":"Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia","volume":"353","author":"Despr\u00e9s","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1124\/pharmrev.122.000600_bib154","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0006-2952(93)90486-G","article-title":"Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist","volume":"46","author":"Deutsch","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib155","doi-asserted-by":"crossref","first-page":"6967","DOI":"10.1074\/jbc.M003161200","article-title":"The cellular uptake of anandamide is coupled to its breakdown by fatty-acid amide hydrolase","volume":"276","author":"Deutsch","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000600_bib156","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1021\/jm00089a018","article-title":"A novel probe for the cannabinoid receptor","volume":"35","author":"Devane","year":"1992","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib157","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0026-895X(25)09876-1","article-title":"Determination and characterization of a cannabinoid receptor in rat brain","volume":"34","author":"Devane","year":"1988","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib158","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"key":"10.1124\/pharmrev.122.000600_bib159","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1089\/can.2019.0103","article-title":"Nausea-induced conditioned gaping reactions in rats produced by high-dose synthetic cannabinoid, JWH-018","volume":"5","author":"DeVuono","year":"2020","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1124\/pharmrev.122.000600_bib161","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrd.2018.115","article-title":"New approaches and challenges to targeting the endocannabinoid system","volume":"17","author":"Di Marzo","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/pharmrev.122.000600_bib162","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0952-3278(95)90077-2","article-title":"Anandamide, an endogenous cannabinomimetic eicosanoid: \u201ckilling two birds with one stone.\u201d","volume":"53","author":"Di Marzo","year":"1995","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1124\/pharmrev.122.000600_bib163","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s13311-015-0374-6","article-title":"The endocannabinoid system and its modulation by phytocannabinoids","volume":"12","author":"Di Marzo","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1124\/pharmrev.122.000600_bib164","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.3390\/nu11081956","article-title":"Lifestyle and metabolic syndrome: contribution of the endocannabinoidome","volume":"11","author":"Di Marzo","year":"2019","journal-title":"Nutrients"},{"key":"10.1124\/pharmrev.122.000600_bib165","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/372686a0","article-title":"Formation and inactivation of endogenous cannabinoid anandamide in central neurons","volume":"372","author":"Di Marzo","year":"1994","journal-title":"Nature"},{"key":"10.1124\/pharmrev.122.000600_bib166","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/35071088","article-title":"Leptin-regulated endocannabinoids are involved in maintaining food intake","volume":"410","author":"Di Marzo","year":"2001","journal-title":"Nature"},{"key":"10.1124\/pharmrev.122.000600_bib167","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.1016\/j.bmc.2004.07.026","article-title":"The anandamide membrane transporter. Structure-activity relationships of anandamide and oleoylethanolamine analogs with phenyl rings in the polar head group region","volume":"12","author":"Di Marzo","year":"2004","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib168","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.3390\/ijms23105430","article-title":"Effects of rare phytocannabinoids on the endocannabinoid system of human keratinocytes","volume":"23","author":"Di Meo","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.122.000600_bib169","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1113\/jphysiol.2005.097477","article-title":"Activity-dependent release and actions of endocannabinoids in the rat hypothalamic supraoptic nucleus","volume":"569","author":"Di","year":"2005","journal-title":"J Physiol"},{"key":"10.1124\/pharmrev.122.000600_bib170","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/cmdc.200900226","article-title":"2,3-Dihydro-1-benzofuran derivatives as a series of potent selective cannabinoid receptor 2 agonists: design, synthesis, and binding mode prediction through ligand-steered modeling","volume":"4","author":"Diaz","year":"2009","journal-title":"ChemMedChem"},{"key":"10.1124\/pharmrev.122.000600_bib171","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10571-006-9072-6","article-title":"Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors","volume":"26","author":"Dickason-Chesterfield","year":"2006","journal-title":"Cell Mol Neurobiol"},{"key":"10.1124\/pharmrev.122.000600_bib172","doi-asserted-by":"crossref","first-page":"6395","DOI":"10.1038\/ncomms7395","article-title":"FAAH genetic variation enhances fronto-amygdala function in mouse and human","volume":"6","author":"Dincheva","year":"2015","journal-title":"Nat Commun"},{"key":"10.1124\/pharmrev.122.000600_bib173","doi-asserted-by":"crossref","first-page":"10819","DOI":"10.1073\/pnas.152334899","article-title":"Brain monoglyceride lipase participating in endocannabinoid inactivation","volume":"99","author":"Dinh","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000600_bib174","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.3390\/cells9122705","article-title":"Mgll knockout mouse resistance to diet-induced dysmetabolism is associated with altered gut microbiota","volume":"9","author":"Dione","year":"2020","journal-title":"Cells"},{"key":"10.1124\/pharmrev.122.000600_bib175","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3390\/nu13041214","article-title":"Endocannabinoids and the gut-brain control of food intake and obesity","volume":"13","author":"DiPatrizio","year":"2021","journal-title":"Nutrients"},{"key":"10.1124\/pharmrev.122.000600_bib176","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.1016\/j.bmcl.2012.06.013","article-title":"C3-heteroaroyl cannabinoids as photolabeling ligands for the CB2 cannabinoid receptor","volume":"22","author":"Dixon","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pharmrev.122.000600_bib177","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.neuropharm.2018.03.020","article-title":"N-oleoyl-glycine reduces nicotine reward and withdrawal in mice","volume":"148","author":"Donvito","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1124\/pharmrev.122.000600_bib178","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.chembiol.2015.04.013","article-title":"Peroxide-dependent MGL sulfenylation regulates 2-AG-mediated endocannabinoid signaling in brain neurons","volume":"22","author":"Dotsey","year":"2015","journal-title":"Chem Biol"},{"key":"10.1124\/pharmrev.122.000600_bib179","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S2215-0366(18)30427-9","article-title":"Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial","volume":"6","author":"D\u2019Souza","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1124\/pharmrev.122.000600_bib180","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1468-3083.2007.02351.x","article-title":"Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study)","volume":"22","author":"Eberlein","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1124\/pharmrev.122.000600_bib181","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1021\/jm00016a013","article-title":"Aminoalkylindoles: structure-activity relationships of novel cannabinoid mimetics","volume":"38","author":"Eissenstat","year":"1995","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib182","first-page":"427","article-title":"Aminoalkylindoles (AAIs): structurally novel cannabinoid-mimetics","volume":"105","author":"Eissenstat","year":"1990","journal-title":"NIDA Res Monogr"},{"key":"10.1124\/pharmrev.122.000600_bib183","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1021\/ml500439x","article-title":"Conformational restriction leading to a selective CB2 cannabinoid receptor agonist orally active against colitis","volume":"6","author":"El Bakali","year":"2014","journal-title":"ACS Med Chem Lett"},{"key":"10.1124\/pharmrev.122.000600_bib184","series-title":"Handbook of Cannabis","first-page":"3","article-title":"Constituents of Cannabis sativa","author":"El Sohly","year":"2014"},{"key":"10.1124\/pharmrev.122.000600_bib185","first-page":"1","article-title":"Phytochemistry of Cannabis sativa L","volume":"103","author":"El Sohly","year":"2017","journal-title":"Prog Chem Org Nat Prod"},{"key":"10.1124\/pharmrev.122.000600_bib186","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.cell.2020.09.022","article-title":"Endocannabinoids inhibit the induction of virulence in enteric pathogens","volume":"183","author":"Ellermann","year":"2020","journal-title":"Cell"},{"key":"10.1124\/pharmrev.122.000600_bib187","doi-asserted-by":"crossref","first-page":"8711","DOI":"10.1074\/jbc.M114.618447","article-title":"Fatty acid-binding proteins (FABPs) are intracellular carriers for \u03949-tetrahydrocannabinol (THC) and cannabidiol (CBD)","volume":"290","author":"Elmes","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000600_bib188","doi-asserted-by":"crossref","first-page":"7588","DOI":"10.1038\/s41598-019-44108-3","article-title":"FABP1 controls hepatic transport and biotransformation of \u03949-THC","volume":"9","author":"Elmes","year":"2019","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.122.000600_bib189","unstructured":"European Medicines Agency (2022) Sativex (https:\/\/www.ema.europa.eu\/en\/medicines?search_api_views_fulltext=Sativex). Emerald Health Pharmaceuticals, https:\/\/emeraldpharma.com\/clinical-trials\/ (accessed October 2022)"},{"key":"10.1124\/pharmrev.122.000600_bib190","doi-asserted-by":"crossref","first-page":"9066","DOI":"10.1073\/pnas.1219451110","article-title":"Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity","volume":"110","author":"Everard","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000600_bib191","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41467-018-08051-7","article-title":"Intestinal epithelial N-acylphosphatidylethanolamine phospholipase D links dietary fat to metabolic adaptations in obesity and steatosis","volume":"10","author":"Everard","year":"2019","journal-title":"Nat Commun"},{"key":"10.1124\/pharmrev.122.000600_bib192","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1016\/j.neuron.2021.05.026","article-title":"In vivo endocannabinoid dynamics at the timescale of physiological and pathological neural activity","volume":"109","author":"Farrell","year":"2021","journal-title":"Neuron"},{"key":"10.1124\/pharmrev.122.000600_bib193","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1046\/j.1432-1033.2003.03724.x","article-title":"Uptake and metabolism of [3H]anandamide by rabbit platelets. Lack of transporter?","volume":"270","author":"Fasia","year":"2003","journal-title":"Eur J Biochem"},{"key":"10.1124\/pharmrev.122.000600_bib194","doi-asserted-by":"crossref","first-page":"936939","DOI":"10.3389\/fncel.2022.936939","article-title":"Fatty acid-binding protein 5 modulates brain endocannabinoid tone and retrograde signaling in the striatum","volume":"16","author":"Fauzan","year":"2022","journal-title":"Front Cell Neurosci"},{"key":"10.1124\/pharmrev.122.000600_bib195","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1080\/17460441.2020.1751118","article-title":"Advances in the discovery of fatty acid amide hydrolase inhibitors: what does the future hold?","volume":"15","author":"Fazio","year":"2020","journal-title":"Expert Opin Drug Discov"},{"key":"10.1124\/pharmrev.122.000600_bib196","doi-asserted-by":"crossref","first-page":"8756","DOI":"10.1073\/pnas.0400997101","article-title":"Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172","volume":"101","author":"Fegley","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000600_bib197","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1124\/mi.6.3.6","article-title":"Cannabinoid biology","volume":"6","author":"Felder","year":"2006","journal-title":"Mol Interv"},{"key":"10.1124\/pharmrev.122.000600_bib198","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0026-895X(25)10492-6","article-title":"Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors","volume":"48","author":"Felder","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib199","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1021\/ci5002718","article-title":"Modeling, molecular dynamics simulation, and mutation validation for structure of cannabinoid receptor 2 based on known crystal structures of GPCRs","volume":"54","author":"Feng","year":"2014","journal-title":"J Chem Inf Model"},{"key":"10.1124\/pharmrev.122.000600_bib200","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s13311-015-0381-7","article-title":"Cannabinoids in neurodegenerative disorders and stroke\/brain trauma: from preclinical models to clinical applications","volume":"12","author":"Fern\u00e1ndez-Ruiz","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1124\/pharmrev.122.000600_bib201","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-3-319-20825-1_8","article-title":"Endocannabinoids and neurodegenerative disorders: Parkinson\u2019s disease, Huntington\u2019s chorea, Alzheimer\u2019s disease, and others","volume":"231","author":"Fern\u00e1ndez-Ruiz","year":"2015","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib202","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.tips.2006.11.001","article-title":"Cannabinoid CB2 receptor: a new target for controlling neural cell survival?","volume":"28","author":"Fern\u00e1ndez-Ruiz","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/pharmrev.122.000600_bib203","doi-asserted-by":"crossref","first-page":"17078","DOI":"10.3390\/molecules191117078","article-title":"Endocannabinoids, related compounds and their metabolic routes","volume":"19","author":"Fezza","year":"2014","journal-title":"Molecules"},{"issue":"Suppl 1","key":"10.1124\/pharmrev.122.000600_bib204","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1097\/j.pain.0000000000002268","article-title":"Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies","volume":"162","author":"Finn","year":"2021","journal-title":"Pain"},{"key":"10.1124\/pharmrev.122.000600_bib205","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/B978-0-12-417197-8.00004-3","article-title":"Constitutive activity in cannabinoid receptors","volume":"70","author":"Fong","year":"2014","journal-title":"Adv Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib206","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41564-019-0655-7","article-title":"Growth effects of N-acylethanolamines on gut bacteria reflect altered bacterial abundances in inflammatory bowel disease","volume":"5","author":"Fornelos","year":"2020","journal-title":"Nat Microbiol"},{"key":"10.1124\/pharmrev.122.000600_bib207","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.542","article-title":"N-Palmitoylglycine and other N-acylamides activate the lipid receptor G2A\/GPR132","volume":"7","author":"Foster","year":"2019","journal-title":"Pharmacol Res Perspect"},{"key":"10.1124\/pharmrev.122.000600_bib208","doi-asserted-by":"crossref","first-page":"eabi8834","DOI":"10.1126\/sciadv.abi8834","article-title":"NAAA-regulated lipid signaling governs the transition from acute to chronic pain","volume":"7","author":"Fotio","year":"2021","journal-title":"Sci Adv"},{"key":"10.1124\/pharmrev.122.000600_bib209","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1124\/jpet.121.000674","article-title":"Antinociceptive profile of ARN19702,(2-ethylsulfonylphenyl)-[(2S)-4-(6-fluoro-1, 3-benzothiazol-2-yl)-2-methylpiperazin-1-yl] methanone, a novel orally active N-acylethanolamine acid amidase inhibitor, in animal models","volume":"378","author":"Fotio","year":"2021","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.122.000600_bib210","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.tips.2012.01.001","article-title":"Anandamide uptake explained?","volume":"33","author":"Fowler","year":"2012","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/pharmrev.122.000600_bib211","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1111\/febs.12212","article-title":"Transport of endocannabinoids across the plasma membrane and within the cell","volume":"280","author":"Fowler","year":"2013","journal-title":"FEBS J"},{"key":"10.1124\/pharmrev.122.000600_bib212","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.tips.2013.12.003","article-title":"Has FLAT fallen flat?","volume":"35","author":"Fowler","year":"2014","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/pharmrev.122.000600_bib213","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/joim.13229","article-title":"The endocannabinoid system\u2014current implications for drug development","volume":"290","author":"Fowler","year":"2021","journal-title":"J Intern Med"},{"key":"10.1124\/pharmrev.122.000600_bib214","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2004.03.048","article-title":"Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis\u2014a difficult issue to handle","volume":"492","author":"Fowler","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib215","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0304-3959(00)00474-7","article-title":"The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain","volume":"92","author":"Fox","year":"2001","journal-title":"Pain"},{"key":"10.1124\/pharmrev.122.000600_bib216","doi-asserted-by":"crossref","first-page":"104801","DOI":"10.1016\/j.phrs.2020.104801","article-title":"Pharmacological potential of varinic-, minor-, and acidic phytocannabinoids","volume":"158","author":"Franco","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1124\/pharmrev.122.000600_bib217","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(93)90468-W","article-title":"Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent","volume":"231","author":"Fride","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib218","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S1474-4422(19)30032-8","article-title":"Safety, efficacy, and mechanisms of action of cannabinoids in neurological disorders","volume":"18","author":"Friedman","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1124\/pharmrev.122.000600_bib219","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1021\/jm7011613","article-title":"Indol-3-yl-tetramethylcyclopropyl ketones: effects of indole ring substitution on CB2 cannabinoid receptor activity","volume":"51","author":"Frost","year":"2008","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib220","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nn.2986","article-title":"A catalytically silent FAAH-1 variant drives anandamide transport in neurons","volume":"15","author":"Fu","year":"2011","journal-title":"Nat Neurosci"},{"key":"10.1124\/pharmrev.122.000600_bib221","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature01921","article-title":"Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha","volume":"425","author":"Fu","year":"2003","journal-title":"Nature"},{"key":"10.1124\/pharmrev.122.000600_bib222","doi-asserted-by":"crossref","first-page":"8066","DOI":"10.1021\/jm401129n","article-title":"Peripherally selective diphenyl purine antagonist of the CB1 receptor","volume":"56","author":"Fulp","year":"2013","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib223","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd2589","article-title":"Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets","volume":"7","author":"Furuhashi","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/pharmrev.122.000600_bib224","doi-asserted-by":"crossref","first-page":"213","DOI":"10.15252\/embr.201439668","article-title":"Active endocannabinoids are secreted on extracellular membrane vesicles","volume":"16","author":"Gabrielli","year":"2015","journal-title":"EMBO Rep"},{"key":"10.1124\/pharmrev.122.000600_bib225","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1021\/acs.jmedchem.8b00368","article-title":"Identification of the first synthetic allosteric modulator of the CB2 receptors and evidence of its efficacy for neuropathic pain relief","volume":"62","author":"Gado","year":"2019","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib226","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1021\/acschembio.2c00122","article-title":"Chemical proteomics reveals off-targets of the anandamide reuptake inhibitor WOBE437","volume":"17","author":"Gagestein","year":"2022","journal-title":"ACS Chem Biol"},{"key":"10.1124\/pharmrev.122.000600_bib227","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1432-1033.1995.tb20780.x","article-title":"Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations","volume":"232","author":"Gali\u00e8gue","year":"1995","journal-title":"Eur J Biochem"},{"key":"10.1124\/pharmrev.122.000600_bib228","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/1874473711104040241","article-title":"Cannabinoid hyperemesis syndrome","volume":"4","author":"Galli","year":"2011","journal-title":"Curr Drug Abuse Rev"},{"key":"10.1124\/pharmrev.122.000600_bib229","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1523\/JNEUROSCI.5693-09.2010","article-title":"Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice","volume":"30","author":"Gao","year":"2010","journal-title":"J Neurosci"},{"key":"10.1124\/pharmrev.122.000600_bib230","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/ja01062a046","article-title":"Isolation, structure and partial synthesis of an active constituent of hashish","volume":"86","author":"Gaoni","year":"1964","journal-title":"J Am Chem Soc"},{"key":"10.1124\/pharmrev.122.000600_bib231","doi-asserted-by":"crossref","first-page":"116421","DOI":"10.1016\/j.bmc.2021.116421","article-title":"Design, synthesis, and pharmacological profiling of cannabinoid 1 receptor allosteric modulators: preclinical efficacy of C2-group GAT211 congeners for reducing intraocular pressure","volume":"50","author":"Garai","year":"2021","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib232","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.bcp.2018.07.047","article-title":"EHP-101, an oral formulation of the cannabidiol aminoquinone VCE-004.8, alleviates bleomycin-induced skin and lung fibrosis","volume":"157","author":"Garc\u00eda-Mart\u00edn","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib233","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0960-894X(95)00573-C","article-title":"Structure activity relationships of tetrahydrocannabinol analogs on human cannabinoid receptors","volume":"6","author":"Gareau","year":"1996","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pharmrev.122.000600_bib234","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.2174\/0929867329666220825161603","article-title":"Recent advances on type-2 cannabinoid (CB2) receptor agonists and their therapeutic potential","volume":"30","author":"Gasperi","year":"2023","journal-title":"Curr Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib235","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0024-3205(97)00690-5","article-title":"Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptors","volume":"61","author":"Gatley","year":"1997","journal-title":"Life Sci"},{"key":"10.1124\/pharmrev.122.000600_bib236","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.1039\/D1SC06659E","article-title":"Detection of cannabinoid receptor type 2 in native cells and zebrafish with a highly potent, cell-permeable fluorescent probe","volume":"13","author":"Gazzi","year":"2022","journal-title":"Chem Sci (Camb)"},{"key":"10.1124\/pharmrev.122.000600_bib237","doi-asserted-by":"crossref","first-page":"7142","DOI":"10.1093\/nar\/18.23.7142","article-title":"Nucleotide sequence of a human cannabinoid receptor cDNA","volume":"18","author":"G\u00e9rard","year":"1990","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/pharmrev.122.000600_bib238","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1042\/bj2790129","article-title":"Molecular cloning of a human cannabinoid receptor which is also expressed in testis","volume":"279","author":"G\u00e9rard","year":"1991","journal-title":"Biochem J"},{"key":"10.1124\/pharmrev.122.000600_bib239","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.1038\/ncomms7495","article-title":"Adipose tissue NAPE-PLD controls fat mass development by altering the browning process and gut microbiota","volume":"6","author":"Geurts","year":"2015","journal-title":"Nat Commun"},{"key":"10.1124\/pharmrev.122.000600_bib240","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1080\/14756366.2021.1912035","article-title":"Different roles for the acyl chain and the amine leaving group in the substrate selectivity of N-acylethanolamine acid amidase","volume":"36","author":"Ghidini","year":"2021","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib241","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1021\/jm061195+","article-title":"Discovery of 2-[(2,4-dichlorophenyl)amino]-N-[(tetrahydro- 2H-pyran-4-yl)methyl]-4-(trifluoromethyl)- 5-pyrimidinecarboxamide, a selective CB2 receptor agonist for the treatment of inflammatory pain","volume":"50","author":"Giblin","year":"2007","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib242","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bcp.2018.07.036","article-title":"Monoacylglycerol lipase (MAGL) as a promising therapeutic target","volume":"157","author":"Gil-Ord\u00f3\u00f1ez","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib243","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.1073\/pnas.0730816100","article-title":"Evidence against the presence of an anandamide transporter","volume":"100","author":"Glaser","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000600_bib244","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.lfs.2005.05.007","article-title":"Anandamide transport: a critical review","volume":"77","author":"Glaser","year":"2005","journal-title":"Life Sci"},{"key":"10.1124\/pharmrev.122.000600_bib245","doi-asserted-by":"crossref","first-page":"18620","DOI":"10.1073\/pnas.0509591102","article-title":"Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis","volume":"102","author":"Gobbi","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000600_bib246","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/bph.14473","article-title":"Opposing roles of CB1 and CB2 cannabinoid receptors in the stimulant and rewarding effects of cocaine","volume":"176","author":"Gobira","year":"2019","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib247","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.prostaglandins.2009.07.001","article-title":"Receptors for acylethanolamides-GPR55 and GPR119","volume":"89","author":"Godlewski","year":"2009","journal-title":"Prostagl Other Lipid Med"},{"key":"10.1124\/pharmrev.122.000600_bib248","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2125734","article-title":"Not just a gut feeling: a deep exploration of functional bacterial metabolites that can modulate host health","volume":"14","author":"Gold","year":"2022","journal-title":"Gut Microbes"},{"key":"10.1124\/pharmrev.122.000600_bib249","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-1-0716-2728-0_6","article-title":"Endocannabinoid-binding receptors as drug targets","volume":"2576","author":"G\u00f3mez-Ca\u00f1as","year":"2023","journal-title":"Methods Mol Biol"},{"key":"10.1124\/pharmrev.122.000600_bib250","doi-asserted-by":"crossref","first-page":"28143","DOI":"10.1074\/jbc.M602364200","article-title":"Characterization of peripheral human cannabinoid receptor (hCB2) expression and pharmacology using a novel radioligand, [35S]Sch225336","volume":"281","author":"Gonsiorek","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000600_bib251","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0083-6729(09)81004-2","article-title":"Anandamide receptor signal transduction","volume":"81","author":"Goodfellow","year":"2009","journal-title":"Vitam Horm"},{"key":"10.1124\/pharmrev.122.000600_bib252","doi-asserted-by":"crossref","first-page":"E10032","DOI":"10.1073\/pnas.1811759115","article-title":"Molecular mechanism of activation of the immunoregulatory amidase NAAA","volume":"115","author":"Gorelik","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000600_bib253","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.eururo.2010.02.027","article-title":"Effects of cannabinor, a novel selective cannabinoid 2 receptor agonist, on bladder function in normal rats","volume":"57","author":"Gratzke","year":"2010","journal-title":"Eur Urol"},{"key":"10.1124\/pharmrev.122.000600_bib254","unstructured":"Grether U (2022) First disclosure of cannabinoid receptor type 2 agonist RG7774\u2014an innovative oral treatment for diabetic retinopathy. XXVII EFMC International Symposium on Medicinal Chemistry, Nice, France."},{"key":"10.1124\/pharmrev.122.000600_bib255","doi-asserted-by":"crossref","first-page":"24770","DOI":"10.1073\/pnas.1916288116","article-title":"N-acyl taurines are endogenous lipid messengers that improve glucose homeostasis","volume":"116","author":"Grevengoed","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000600_bib256","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/bph.13226","article-title":"Role of the endocannabinoid system in diabetes and diabetic complications","volume":"173","author":"Gruden","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib257","series-title":"New Tools to Interrogate Endocannabinoid Signaling. From Natural Compounds to Synthetic Drugs","first-page":"89","article-title":"Natural compounds and synthetic drugs to target type-2 cannabinoid (CB2) receptor","author":"Guba","year":"2020"},{"key":"10.1124\/pharmrev.122.000600_bib258","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2533\/chimia.2022.425","article-title":"Reverse design toward optimized labeled chemical probes\u2014examples from the endocannabinoid system","volume":"76","author":"Guberman","year":"2022","journal-title":"Chimia (Aarau)"},{"key":"10.1124\/pharmrev.122.000600_bib259","doi-asserted-by":"crossref","first-page":"pyw068","DOI":"10.1093\/ijnp\/pyw068","article-title":"The CB1 neutral antagonist AM4113 retains the therapeutic efficacy of the inverse agonist rimonabant for nicotine dependence and weight loss with better psychiatric tolerability","volume":"19","author":"Gueye","year":"2016","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib260","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bbi.2017.09.001","article-title":"Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice","volume":"67","author":"Guida","year":"2018","journal-title":"Brain Behav Immun"},{"key":"10.1124\/pharmrev.122.000600_bib261","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.bjp.0707531","article-title":"Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain","volume":"153","author":"Guindon","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib262","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.3390\/molecules26175213","article-title":"Involvement of the \u03b3 isoform of cPLA2 in the biosynthesis of bioactive N-acylethanolamines","volume":"26","author":"Guo","year":"2021","journal-title":"Molecules"},{"key":"10.1124\/pharmrev.122.000600_bib263","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1016\/j.bja.2019.02.019","article-title":"Microdeletion in a FAAH pseudogene identified in a patient with high anandamide concentrations and pain insensitivity","volume":"123","author":"Habib","year":"2019","journal-title":"Br J Anaesth"},{"key":"10.1124\/pharmrev.122.000600_bib264","doi-asserted-by":"crossref","first-page":"10287","DOI":"10.1021\/acs.jmedchem.0c00778","article-title":"Identification and preclinical development of a 2,5,6-trisubstituted fluorinated pyridine derivative as a radioligand for the positron emission tomography imaging of cannabinoid type 2 receptors","volume":"63","author":"Haider","year":"2020","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib265","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1073\/pnas.1721339115","article-title":"Fatty-acid-binding protein 5 controls retrograde endocannabinoid signaling at central glutamate synapses","volume":"115","author":"Haj-Dahmane","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000600_bib266","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1021\/np500292g","article-title":"Identification of endocannabinoid system-modulating N-alkylamides from Heliopsis helianthoides var. scabra and Lepidium meyenii","volume":"77","author":"Hajdu","year":"2014","journal-title":"J Nat Prod"},{"key":"10.1124\/pharmrev.122.000600_bib267","doi-asserted-by":"crossref","first-page":"426","DOI":"10.2174\/1389557514666140428105753","article-title":"Latest progress in the identification of novel synthetic ligands for the cannabinoid CB2 receptor","volume":"14","author":"Han","year":"2014","journal-title":"Mini Rev Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib268","doi-asserted-by":"crossref","first-page":"8224","DOI":"10.1021\/jm4005626","article-title":"Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists","volume":"56","author":"Han","year":"2013","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib269","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1021\/acsmedchemlett.7b00396","article-title":"Discovery of APD371: identification of a highly potent and selective CB2 agonist for the treatment of chronic pain","volume":"8","author":"Han","year":"2017","journal-title":"ACS Med Chem Lett"},{"key":"10.1124\/pharmrev.122.000600_bib270","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/bph.14175","article-title":"Non-endocannabinoid N-acylethanolamines and 2-monoacylglycerols in the intestine","volume":"176","author":"Hansen","year":"2019","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib271","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1073\/pnas.061029898","article-title":"2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor","volume":"98","author":"Hanus","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000600_bib272","doi-asserted-by":"crossref","first-page":"14228","DOI":"10.1073\/pnas.96.25.14228","article-title":"HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor","volume":"96","author":"Hanus","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000600_bib273","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1039\/C6NP00074F","article-title":"Phytocannabinoids: a unified critical inventory","volume":"33","author":"Hanu\u0161","year":"2016","journal-title":"Nat Prod Rep"},{"key":"10.1124\/pharmrev.122.000600_bib274","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000371890","article-title":"S-777469, a novel cannabinoid type 2 receptor agonist, suppresses itch-associated scratching behavior in rodents through inhibition of itch signal transmission","volume":"95","author":"Haruna","year":"2015","journal-title":"Pharmacology"},{"key":"10.1124\/pharmrev.122.000600_bib275","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000455916","article-title":"The inhibitory effect of S-777469, a cannabinoid type 2 receptor agonist, on skin inflammation in mice","volume":"99","author":"Haruna","year":"2017","journal-title":"Pharmacology"},{"key":"10.1124\/pharmrev.122.000600_bib276","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41401-018-0059-x","article-title":"Cannabinoid CB1 receptor neutral antagonist AM4113 inhibits heroin self-administration without depressive side effects in rats","volume":"40","author":"He","year":"2019","journal-title":"Acta Pharmacol Sin"},{"key":"10.1124\/pharmrev.122.000600_bib277","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2018.05.027","article-title":"Acute oral cannabidiolic acid methyl ester reduces depression-like behavior in two genetic animal models of depression","volume":"351","author":"Hen-Shoval","year":"2018","journal-title":"Behav Brain Res"},{"key":"10.1124\/pharmrev.122.000600_bib278","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","article-title":"Cannabinoid receptor localization in brain","volume":"87","author":"Herkenham","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000600_bib279","doi-asserted-by":"crossref","first-page":"13765","DOI":"10.1002\/anie.201407807","article-title":"A reversible and selective inhibitor of monoacylglycerol lipase ameliorates multiple sclerosis","volume":"53","author":"Hern\u00e1ndez-Torres","year":"2014","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1124\/pharmrev.122.000600_bib280","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0009-3084(00)00191-2","article-title":"The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes","volume":"108","author":"Hillard","year":"2000","journal-title":"Chem Phys Lipids"},{"key":"10.1124\/pharmrev.122.000600_bib281","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/sj.bjp.0705468","article-title":"Cellular accumulation of anandamide: consensus and controversy","volume":"140","author":"Hillard","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib282","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1046\/j.1471-4159.1997.69020631.x","article-title":"Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion","volume":"69","author":"Hillard","year":"1997","journal-title":"J Neurochem"},{"key":"10.1124\/pharmrev.122.000600_bib283","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/bs.mie.2017.06.017","article-title":"Endocannabinoid transport proteins: discovery of tools to study sterol carrier protein-2","volume":"593","author":"Hillard","year":"2017","journal-title":"Methods Enzymol"},{"key":"10.1124\/pharmrev.122.000600_bib284","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0022-3565(24)38289-8","article-title":"Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1)","volume":"289","author":"Hillard","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.122.000600_bib285","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s12031-007-0045-0","article-title":"Studies of anandamide accumulation inhibitors in cerebellar granule neurons: comparison to inhibition of fatty acid amide hydrolase","volume":"33","author":"Hillard","year":"2007","journal-title":"J Mol Neurosci"},{"key":"10.1124\/pharmrev.122.000600_bib286","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0005-2760(95)00087-S","article-title":"Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain","volume":"1257","author":"Hillard","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pharmrev.122.000600_bib287","doi-asserted-by":"crossref","first-page":"31405","DOI":"10.1074\/jbc.M501489200","article-title":"Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system","volume":"280","author":"H\u00f6gest\u00e4tt","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000600_bib288","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/nature03658","article-title":"An endocannabinoid mechanism for stress-induced analgesia","volume":"435","author":"Hohmann","year":"2005","journal-title":"Nature"},{"key":"10.1124\/pharmrev.122.000600_bib289","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.1021\/jm400305d","article-title":"Selective cannabinoid receptor type 2 (CB2) agonists: optimization of a series of purines leading to the identification of a clinical candidate for the treatment of osteoarthritic pain","volume":"56","author":"Hollinshead","year":"2013","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib290","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s11255-016-1329-5","article-title":"Anandamide transporter-mediated regulation of the micturition reflex in urethane-anesthetized rats","volume":"48","author":"Honda","year":"2016","journal-title":"Int Urol Nephrol"},{"key":"10.1124\/pharmrev.122.000600_bib291","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/j.drudis.2014.08.012","article-title":"Radioligand development for molecular imaging of the central nervous system with positron emission tomography","volume":"19","author":"Honer","year":"2014","journal-title":"Drug Discov Today"},{"key":"10.1124\/pharmrev.122.000600_bib292","doi-asserted-by":"crossref","first-page":"0010","DOI":"10.1038\/s41551-016-0010","article-title":"Near-infrared fluorophores for biomedical imaging","volume":"1","author":"Hong","year":"2017","journal-title":"Nat Biomed Eng"},{"key":"10.1124\/pharmrev.122.000600_bib293","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/biof.1911","article-title":"Fatty acid amide hydrolase C385A polymorphism affects susceptibility to various diseases","volume":"49","author":"Hosseinzadeh Anvar","year":"2023","journal-title":"Biofactors"},{"key":"10.1124\/pharmrev.122.000600_bib294","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/0024-3205(84)90278-9","article-title":"Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds","volume":"35","author":"Howlett","year":"1984","journal-title":"Life Sci"},{"key":"10.1124\/pharmrev.122.000600_bib295","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/bs.apha.2017.03.007","article-title":"CB1 and CB2 receptor pharmacology","volume":"80","author":"Howlett","year":"2017","journal-title":"Adv Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib296","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International Union of Pharmacology. XXVII. Classification of cannabinoid receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol Rev"},{"key":"10.1124\/pharmrev.122.000600_bib297","first-page":"100","article-title":"Classical and nonclassical cannabinoids: mechanism of action\u2014brain binding","volume":"96","author":"Howlett","year":"1990","journal-title":"NIDA Res Monogr"},{"key":"10.1124\/pharmrev.122.000600_bib298","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0026-895X(25)13196-9","article-title":"Nonclassical cannabinoid analgetics inhibit adenylate cyclase: development of a cannabinoid receptor model","volume":"33","author":"Howlett","year":"1988","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib299","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1476-5381.2011.01364.x","article-title":"Endocannabinoid tone versus constitutive activity of cannabinoid receptors","volume":"163","author":"Howlett","year":"2011","journal-title":"Br Journal Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib300","doi-asserted-by":"crossref","first-page":"5874","DOI":"10.3390\/ijms20235874","article-title":"Allosteric modulation of cannabinoid receptor 1\u2014current challenges and future opportunities","volume":"20","author":"Hryhorowicz","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.122.000600_bib301","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1021\/acs.biochem.7b00194","article-title":"The antinociceptive agent SBFI-26 binds to anandamide transporters FABP5 and FABP7 at two different sites","volume":"56","author":"Hsu","year":"2017","journal-title":"Biochemistry"},{"key":"10.1124\/pharmrev.122.000600_bib302","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/nchembio.1105","article-title":"DAGL\u03b2 inhibition perturbs a lipid network involved in macrophage inflammatory responses","volume":"8","author":"Hsu","year":"2012","journal-title":"Nat Chem Biol"},{"key":"10.1124\/pharmrev.122.000600_bib303","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.cell.2020.01.008","article-title":"Activation and signaling mechanism revealed by cannabinoid receptor-Gi complex structures","volume":"180","author":"Hua","year":"2020","journal-title":"Cell"},{"key":"10.1124\/pharmrev.122.000600_bib304","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/nature23272","article-title":"Crystal structures of agonist-bound human cannabinoid receptor CB1","volume":"547","author":"Hua","year":"2017","journal-title":"Nature"},{"key":"10.1124\/pharmrev.122.000600_bib305","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.cell.2016.10.004","article-title":"Crystal structure of the human cannabinoid receptor CB1","volume":"167","author":"Hua","year":"2016","journal-title":"Cell"},{"key":"10.1124\/pharmrev.122.000600_bib1500","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1021\/acs.biochem.8b00744","article-title":"Structural and Functional Interaction of \u03949-Tetrahydrocannabinol with Liver Fatty Acid Binding Protein (FABP1)","volume":"57","author":"Huang","year":"2018","journal-title":"Biochemistry"},{"key":"10.1124\/pharmrev.122.000600_bib306","doi-asserted-by":"crossref","first-page":"42639","DOI":"10.1074\/jbc.M107351200","article-title":"Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain","volume":"276","author":"Huang","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000600_bib307","doi-asserted-by":"crossref","first-page":"8400","DOI":"10.1073\/pnas.122196999","article-title":"An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors","volume":"99","author":"Huang","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000600_bib308","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/cbdv.200790152","article-title":"Human cannabinoid pharmacokinetics","volume":"4","author":"Huestis","year":"2007","journal-title":"Chem Biodivers"},{"key":"10.1124\/pharmrev.122.000600_bib309","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1021\/jm960394y","article-title":"Synthesis and pharmacology of a very potent cannabinoid lacking a phenolic hydroxyl with high affinity for the CB2 receptor","volume":"39","author":"Huffman","year":"1996","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib310","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.pain.2012.04.020","volume":"153","author":"Huggins","year":"2012","journal-title":"Pain"},{"key":"10.1124\/pharmrev.122.000600_bib311","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.plipres.2016.02.002","article-title":"Endocannabinoids and endocannabinoid-related mediators: targets, metabolism and role in neurological disorders","volume":"62","author":"Iannotti","year":"2016","journal-title":"Prog Lipid Res"},{"key":"10.1124\/pharmrev.122.000600_bib312","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s13311-015-0377-3","article-title":"Molecular targets of cannabidiol in neurological disorders","volume":"12","author":"Ibeas Bih","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1124\/pharmrev.122.000600_bib313","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1089\/can.2016.0037","article-title":"Cannabinoid CB(1) and CB(2) receptor signaling and bias","volume":"2","author":"Ibsen","year":"2017","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1124\/pharmrev.122.000600_bib314","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1038\/npp.2015.148","article-title":"A cannabinoid CB1 receptor-positive allosteric modulator reduces neuropathic pain in the mouse with no psychoactive effects","volume":"40","author":"Ignatowska-Jankowska","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pharmrev.122.000600_bib315","doi-asserted-by":"crossref","first-page":"108273","DOI":"10.1016\/j.pharmthera.2022.108273","article-title":"Short-chain fatty acid receptors and gut microbiota as therapeutic targets in metabolic, immune, and neurological diseases","volume":"239","author":"Ikeda","year":"2022","journal-title":"Pharmacol Ther"},{"key":"10.1124\/pharmrev.122.000600_bib316","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3389\/fnins.2018.00733","article-title":"The endocannabinoid system and oligodendrocytes in health and disease","volume":"12","author":"Ilyasov","year":"2018","journal-title":"Front Neurosci"},{"key":"10.1124\/pharmrev.122.000600_bib317","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.3390\/ijms22031034","article-title":"GPR119 and GPR55 as receptors for fatty acid ethanolamides, oleoylethanolamide and palmitoylethanolamide","volume":"22","author":"Im","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.122.000600_bib318","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/jb\/mvx054","article-title":"Peripheral tissue levels and molecular species compositions of N-acyl-phosphatidylethanolamine and its metabolites in mice lacking N-acyl-phosphatidylethanolamine-specific phospholipase D","volume":"162","author":"Inoue","year":"2017","journal-title":"J Biochem"},{"key":"10.1124\/pharmrev.122.000600_bib319","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.biopsych.2009.09.024","article-title":"Brain cannabinoid CB2 receptor in schizophrenia","volume":"67","author":"Ishiguro","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pharmrev.122.000600_bib320","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bmcl.2014.11.062","article-title":"Identification of a highly potent and selective CB2 agonist, RQ-00202730, for the treatment of irritable bowel syndrome","volume":"25","author":"Iwata","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pharmrev.122.000600_bib321","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1021\/acs.jmedchem.1c01836","article-title":"Synthesis, biological evaluation, and molecular modeling studies of 3, 4-diarylpyrazoline series of compounds as potent, nonbrain penetrant antagonists of cannabinoid-1 (CB1R) receptor with reduced lipophilicity","volume":"65","author":"Iyer","year":"2022","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib322","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.euroneuro.2018.12.014","article-title":"A systematic review of phytocannabinoid exposure on the endocannabinoid system: implications for psychosis","volume":"29","author":"Jacobson","year":"2019","journal-title":"Eur Neuropsychopharmacol"},{"issue":"Suppl 1","key":"10.1124\/pharmrev.122.000600_bib323","first-page":"320S","article-title":"Evaluation of intramuscular levonantradol and placebo in acute postoperative pain","volume":"21","author":"Jain","year":"1981","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib324","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/bs.mie.2017.06.022","article-title":"Ligand-assisted protein structure (LAPS): an experimental paradigm for characterizing cannabinoid-receptor ligand-binding domains","volume":"593","author":"Janero","year":"2017","journal-title":"Methods Enzymol"},{"key":"10.1124\/pharmrev.122.000600_bib325","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1016\/j.bmcl.2016.06.076","article-title":"Inhibitors of diacylglycerol lipases in neurodegenerative and metabolic disorders","volume":"26","author":"Janssen","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pharmrev.122.000600_bib326","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1046\/j.1471-4159.2000.0742597.x","article-title":"Structure-activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter","volume":"74","author":"Jarrahian","year":"2000","journal-title":"J Neurochem"},{"key":"10.1124\/pharmrev.122.000600_bib328","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.biopsych.2015.03.033","article-title":"Anxiety, stress, and fear response in mice with reduced endocannabinoid levels","volume":"79","author":"Jenniches","year":"2016","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pharmrev.122.000600_bib329","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4103\/idoj.IDOJ_62_16","article-title":"Bimatoprost in dermatology","volume":"9","author":"Jha","year":"2018","journal-title":"Indian Dermatol Online J"},{"key":"10.1124\/pharmrev.122.000600_bib330","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1074\/jbc.M606369200","article-title":"Discovery and characterization of a Ca2+-independent phosphatidylethanolamine N-acyltransferase generating the anandamide precursor and its congeners","volume":"282","author":"Jin","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000600_bib331","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2112971118","article-title":"Phospholipase C\u03b32 regulates endocannabinoid and eicosanoid networks in innate immune cells","volume":"118","author":"Jing","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000600_bib332","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.pain.2004.02.020","article-title":"Activation of peripheral cannabinoid receptors attenuates cutaneous hyperalgesia produced by a heat injury","volume":"109","author":"Johanek","year":"2004","journal-title":"Pain"},{"issue":"Suppl 1","key":"10.1124\/pharmrev.122.000600_bib333","first-page":"271S","article-title":"Selective and potent analgetics derived from cannabinoids","volume":"21","author":"Johnson","year":"1981","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib334","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/sj.bjp.0704199","article-title":"Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide","volume":"133","author":"Jonsson","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib335","doi-asserted-by":"crossref","first-page":"E5420","DOI":"10.1073\/pnas.1419901111","article-title":"Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy","volume":"111","author":"Jourdan","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000600_bib336","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1124\/mol.107.037796","article-title":"A key role for diacylglycerol lipase-alpha in metabotropic glutamate receptor-dependent endocannabinoid mobilization","volume":"72","author":"Jung","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib337","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/ncomms2045","article-title":"Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome","volume":"3","author":"Jung","year":"2012","journal-title":"Nat Commun"},{"key":"10.1124\/pharmrev.122.000600_bib338","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.biopsych.2008.08.008","article-title":"Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates","volume":"64","author":"Justinova","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pharmrev.122.000600_bib339","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1038\/npp.2015.62","article-title":"Effects of fatty acid amide hydrolase (FAAH) inhibitors in non-human primate models of nicotine reward and relapse","volume":"40","author":"Justinova","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pharmrev.122.000600_bib340","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1111\/bph.15469","article-title":"Mechanisms of endocannabinoid transport in the brain","volume":"179","author":"Kaczocha","year":"2022","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib341","doi-asserted-by":"crossref","first-page":"6375","DOI":"10.1073\/pnas.0901515106","article-title":"Identification of intracellular carriers for the endocannabinoid anandamide","volume":"106","author":"Kaczocha","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000600_bib342","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1074\/jbc.M109.058461","article-title":"Lipid droplets are novel sites of N-acylethanolamine inactivation by fatty acid amide hydrolase-2","volume":"285","author":"Kaczocha","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000600_bib343","doi-asserted-by":"crossref","first-page":"9066","DOI":"10.1074\/jbc.M509721200","article-title":"Anandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by fatty acid amide hydrolase","volume":"281","author":"Kaczocha","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000600_bib344","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094200","article-title":"Inhibition of fatty acid binding proteins elevates brain anandamide levels and produces analgesia","volume":"9","author":"Kaczocha","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.122.000600_bib345","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1074\/jbc.M111.304907","article-title":"Fatty acid-binding proteins transport N-acylethanolamines to nuclear receptors and are targets of endocannabinoid transport inhibitors","volume":"287","author":"Kaczocha","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000600_bib346","doi-asserted-by":"crossref","first-page":"104483","DOI":"10.1016\/j.yrtph.2019.104483","article-title":"Preclinical toxicity evaluation of JD5037, a peripherally restricted CB1 receptor inverse agonist, in rats and dogs for treatment of nonalcoholic steatohepatitis","volume":"109","author":"Kale","year":"2019","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib347","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/1440-1681.12051","article-title":"Evaluation of the analgesic efficacy and psychoactive effects of AZD1940, a novel peripherally acting cannabinoid agonist, in human capsaicin-induced pain and hyperalgesia","volume":"40","author":"Kalliom\u00e4ki","year":"2013","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1124\/pharmrev.122.000600_bib348","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1152\/physrev.00019.2008","article-title":"Endocannabinoid-mediated control of synaptic transmission","volume":"89","author":"Kano","year":"2009","journal-title":"Physiol Rev"},{"key":"10.1124\/pharmrev.122.000600_bib349","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1194\/jlr.D070433","article-title":"Quantitative profiling of endocannabinoids and related N-acylethanolamines in human CSF using nano LC-MS\/MS","volume":"58","author":"Kantae","year":"2017","journal-title":"J Lipid Res"},{"key":"10.1124\/pharmrev.122.000600_bib350","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1001\/jama.290.13.1757","article-title":"Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial","volume":"290","author":"Karst","year":"2003","journal-title":"JAMA"},{"key":"10.1124\/pharmrev.122.000600_bib351","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1388-1981(99)00124-9","article-title":"Equilibrium in the hydrolysis and synthesis of cannabimimetic anandamide demonstrated by a purified enzyme","volume":"1440","author":"Katayama","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pharmrev.122.000600_bib352","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0005-2760(97)00078-7","article-title":"Distribution of anandamide amidohydrolase in rat tissues with special reference to small intestine","volume":"1347","author":"Katayama","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pharmrev.122.000600_bib353","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nm803","article-title":"Modulation of anxiety through blockade of anandamide hydrolysis","volume":"9","author":"Kathuria","year":"2003","journal-title":"Nat Med"},{"key":"10.1124\/pharmrev.122.000600_bib354","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1016\/j.bmcl.2008.07.081","article-title":"Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase","volume":"18","author":"Keith","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pharmrev.122.000600_bib355","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1124\/pr.108.000992","article-title":"Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery","volume":"62","author":"Kenakin","year":"2010","journal-title":"Pharmacol Rev"},{"key":"10.1124\/pharmrev.122.000600_bib356","first-page":"294","article-title":"Cannabinoid receptors in the central nervous system: their signaling and roles in disease","volume":"10","author":"Kendall","year":"2016","journal-title":"Front Cell Neurosci"},{"key":"10.1124\/pharmrev.122.000600_bib357","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1056\/NEJMoa1604221","article-title":"Acute neurologic disorder from an inhibitor of fatty acid amide hydrolase","volume":"375","author":"Kerbrat","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1124\/pharmrev.122.000600_bib358","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1007\/s11033-022-07223-5","article-title":"Cannabinoid and endocannabinoid system: a promising therapeutic intervention for multiple sclerosis","volume":"49","author":"Khan","year":"2022","journal-title":"Mol Biol Rep"},{"key":"10.1124\/pharmrev.122.000600_bib359","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1021\/jm960152y","article-title":"Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand","volume":"39","author":"Khanolkar","year":"1996","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib360","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3324\/haematol.2021.280460","article-title":"Inhibition of DAGL\u03b2 as a therapeutic target for pain in sickle cell disease","volume":"108","author":"Khasabova","year":"2023","journal-title":"Haematologica"},{"key":"10.1124\/pharmrev.122.000600_bib361","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neuropharm.2017.05.018","article-title":"Modulation of CB1 cannabinoid receptor by allosteric ligands: pharmacology and therapeutic opportunities","volume":"124","author":"Khurana","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1124\/pharmrev.122.000600_bib362","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1254\/jphs.FP0071599","article-title":"Pharmacological evaluation of a novel cannabinoid 2 (CB2) ligand, PF-03550096, in vitro and in vivo by using a rat model of visceral hypersensitivity","volume":"106","author":"Kikuchi","year":"2008","journal-title":"J Pharmacol Sci"},{"key":"10.1124\/pharmrev.122.000600_bib363","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1042\/EBC20190086","article-title":"The endocannabinoid system","volume":"64","author":"Kilaru","year":"2020","journal-title":"Essays Biochem"},{"key":"10.1124\/pharmrev.122.000600_bib364","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1124\/jpet.109.155465","article-title":"Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain","volume":"330","author":"Kinsey","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.122.000600_bib366","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/jb\/mvi021","article-title":"Endogenous cannabinoid receptor ligand induces the migration of human natural killer cells","volume":"137","author":"Kishimoto","year":"2005","journal-title":"J Biochem"},{"key":"10.1124\/pharmrev.122.000600_bib367","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11481-005-9007-x","article-title":"Cannabinoid-induced immune suppression and modulation of antigen-presenting cells","volume":"1","author":"Klein","year":"2006","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib368","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.bcp.2012.02.014","article-title":"Cannabinoid receptor trafficking in peripheral cells is dynamically regulated by a binary biochemical switch","volume":"83","author":"Kleyer","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib369","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.3390\/molecules26185601","article-title":"Novel CBG derivatives can reduce inflammation, pain and obesity","volume":"26","author":"Kogan","year":"2021","journal-title":"Molecules"},{"key":"10.1124\/pharmrev.122.000600_bib371","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e11336","article-title":"The involvement of peroxisome proliferator-activated receptor gamma (PPAR\u03b3) in anti-inflammatory activity of N-stearoylethanolamine","volume":"8","author":"Kosiakova","year":"2022","journal-title":"Heliyon"},{"key":"10.1124\/pharmrev.122.000600_bib372","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.cell.2018.11.040","article-title":"Structure of a signaling cannabinoid receptor 1-G protein complex","volume":"176","author":"Krishna Kumar","year":"2019","journal-title":"Cell"},{"key":"10.1124\/pharmrev.122.000600_bib374","doi-asserted-by":"crossref","first-page":"e00407","DOI":"10.1128\/msystems.00407-19","article-title":"Rapid and concomitant gut microbiota and endocannabinoidome response to diet-induced obesity in mice","volume":"4","author":"Lacroix","year":"2019","journal-title":"mSystems"},{"key":"10.1124\/pharmrev.122.000600_bib375","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3390\/ijms22031001","article-title":"Relevance of peroxisome proliferator activated receptors in multitarget paradigm associated with the endocannabinoid system","volume":"22","author":"Lago-Fernandez","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.122.000600_bib376","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1021\/jm058183t","article-title":"The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications","volume":"48","author":"Lambert","year":"2005","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib377","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1021\/jm980363y","article-title":"Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists","volume":"42","author":"Lan","year":"1999","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib378","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib379","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1124\/mol.115.101980","article-title":"Biased type 1 cannabinoid receptor signaling influences neuronal viability in a cell culture model of Huntington disease","volume":"89","author":"Laprairie","year":"2016","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib380","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.bmcl.2004.11.007","article-title":"Triaryl bis-sulfones as a new class of cannabinoid CB2 receptor inhibitors: identification of a lead and initial SAR studies","volume":"15","author":"Lavey","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pharmrev.122.000600_bib381","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.biopsych.2022.04.017","article-title":"Frequent low-dose \u03949-tetrahydrocannabinol in adolescence disrupts microglia homeostasis and disables responses to microbial infection and social stress in young adulthood","volume":"92","author":"Lee","year":"2022","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pharmrev.122.000600_bib382","doi-asserted-by":"crossref","first-page":"eaay8937","DOI":"10.1126\/sciadv.aay8937","article-title":"Retinol-binding protein 2 (RBP2) binds monoacylglycerols and modulates gut endocrine signaling and body weight","volume":"6","author":"Lee","year":"2020","journal-title":"Sci Adv"},{"key":"10.1124\/pharmrev.122.000600_bib383","doi-asserted-by":"crossref","first-page":"G655","DOI":"10.1152\/ajpgi.00294.2015","article-title":"Endocannabinoids in the gastrointestinal tract","volume":"311","author":"Lee","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/pharmrev.122.000600_bib384","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3390\/cells9051247","article-title":"Hepatic NAPE-PLD is a key regulator of liver lipid metabolism","volume":"9","author":"Lefort","year":"2020","journal-title":"Cells"},{"key":"10.1124\/pharmrev.122.000600_bib385","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.bjp.0705607","article-title":"Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors","volume":"141","author":"Leggett","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib386","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jare.2021.11.011","article-title":"Fatty acid-binding protein 5 aggravates pulmonary artery fibrosis in pulmonary hypertension secondary to left heart disease via activating wnt\/\u03b2-catenin pathway","volume":"40","author":"Lei","year":"2022","journal-title":"J Adv Res"},{"key":"10.1124\/pharmrev.122.000600_bib387","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.bbalip.2016.03.003","article-title":"Lipidomics profile of a NAPE-PLD KO mouse provides evidence of a broader role of this enzyme in lipid metabolism in the brain","volume":"1861","author":"Leishman","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pharmrev.122.000600_bib388","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/cpt1975186720","article-title":"Clinical pharmacology of nabilone, a cannabinol derivative","volume":"18","author":"Lemberger","year":"1975","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pharmrev.122.000600_bib389","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.3390\/molecules26175413","article-title":"CB1 cannabinoid receptor signaling and biased signaling","volume":"26","author":"Leo","year":"2021","journal-title":"Molecules"},{"key":"10.1124\/pharmrev.122.000600_bib390","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1021\/bi060163l","article-title":"Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids","volume":"45","author":"Leung","year":"2006","journal-title":"Biochemistry"},{"key":"10.1124\/pharmrev.122.000600_bib391","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079355","article-title":"Role of FAAH-like anandamide transporter in anandamide inactivation","volume":"8","author":"Leung","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.122.000600_bib392","doi-asserted-by":"crossref","first-page":"6057","DOI":"10.3390\/molecules27186057","article-title":"Analysis of anti-cancer and anti-inflammatory properties of 25 high-THC cannabis extracts","volume":"27","author":"Li","year":"2022","journal-title":"Molecules"},{"key":"10.1124\/pharmrev.122.000600_bib393","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1038\/s41467-023-37112-9","article-title":"Structural basis of selective cannabinoid CB2 receptor activation","volume":"14","author":"Li","year":"2023","journal-title":"Nat Commun"},{"key":"10.1124\/pharmrev.122.000600_bib394","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cell.2018.12.011","article-title":"Crystal structure of the human cannabinoid receptor CB2","volume":"176","author":"Li","year":"2019","journal-title":"Cell"},{"key":"10.1124\/pharmrev.122.000600_bib395","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101958R","article-title":"Group IVE cytosolic phospholipase A2 limits psoriatic inflammation by mobilizing the anti-inflammatory lipid N-acylethanolamine","volume":"36","author":"Liang","year":"2022","journal-title":"FASEB J"},{"key":"10.1124\/pharmrev.122.000600_bib396","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12035-014-8651-7","article-title":"Sterol carrier protein-2: binding protein for endocannabinoids","volume":"50","author":"Liedhegner","year":"2014","journal-title":"Mol Neurobiol"},{"key":"10.1124\/pharmrev.122.000600_bib397","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1152\/physrev.00002.2016","article-title":"From phytocannabinoids to cannabinoid receptors and endocannabinoids: pleiotropic physiological and pathological roles through complex pharmacology","volume":"96","author":"Ligresti","year":"2016","journal-title":"Physiol Rev"},{"key":"10.1124\/pharmrev.122.000600_bib398","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1042\/bj20031812","article-title":"Further evidence for the existence of a specific process for the membrane transport of anandamide","volume":"380","author":"Ligresti","year":"2004","journal-title":"Biochem J"},{"key":"10.1124\/pharmrev.122.000600_bib399","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1476-5381.2010.00885.x","article-title":"Inverse agonism of cannabinoid CB1 receptors potentiates LiCl-induced nausea in the conditioned gaping model in rats","volume":"161","author":"Limebeer","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib400","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1590\/1516-4446-2017-0015","article-title":"Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test","volume":"41","author":"Linares","year":"2019","journal-title":"Br J Psychiatry"},{"key":"10.1124\/pharmrev.122.000600_bib401","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.biomaterials.2015.04.018","article-title":"A novel near-infrared fluorescence imaging probe that preferentially binds to cannabinoid receptors CB2R over CB1R","volume":"57","author":"Ling","year":"2015","journal-title":"Biomaterials"},{"key":"10.1124\/pharmrev.122.000600_bib402","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.3390\/cells11101592","article-title":"The human Ntn-hydrolase superfamily: structure, functions and perspectives","volume":"11","author":"Linhorst","year":"2022","journal-title":"Cells"},{"key":"10.1124\/pharmrev.122.000600_bib403","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1042\/bj3460835","article-title":"Functional CB1 cannabinoid receptors in human vascular endothelial cells","volume":"346","author":"Liu","year":"2000","journal-title":"Biochem J"},{"key":"10.1124\/pharmrev.122.000600_bib404","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1038\/s41467-022-31168-9","article-title":"Deficiency in endocannabinoid synthase DAGLB contributes to early onset parkinsonism and murine nigral dopaminergic neuron dysfunction","volume":"13","author":"Liu","year":"2022","journal-title":"Nat Commun"},{"key":"10.1124\/pharmrev.122.000600_bib405","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1007\/s00213-015-3917-y","article-title":"2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons","volume":"232","author":"Llorente-Berzal","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.122.000600_bib406","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1124\/mol.104.006353","article-title":"The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide","volume":"67","author":"Lo Verme","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib407","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nchembio.129","article-title":"Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects","volume":"5","author":"Long","year":"2009","journal-title":"Nat Chem Biol"},{"key":"10.1124\/pharmrev.122.000600_bib408","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00334-016-0579-6","article-title":"Cannabis in Eurasia: origin of human use and Bronze Age trans-continental connections","volume":"26","author":"Long","year":"2017","journal-title":"Veg Hist Archaeobot"},{"key":"10.1124\/pharmrev.122.000600_bib409","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0223-5234(03)00045-X","article-title":"Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors","volume":"38","author":"L\u00f3pez-Rodr\u00edguez","year":"2003","journal-title":"Eur J Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib410","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1021\/jm0210818","article-title":"Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase","volume":"46","author":"L\u00f3pez-Rodr\u00edguez","year":"2003","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib411","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1021\/jm015545y","article-title":"Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors","volume":"44","author":"L\u00f3pez-Rodr\u00edguez","year":"2001","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib412","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ejp.1148","article-title":"Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings","volume":"22","author":"L\u00f6tsch","year":"2018","journal-title":"Eur J Pain"},{"key":"10.1124\/pharmrev.122.000600_bib413","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1139\/cjpp-2016-0346","article-title":"Cannabinoid signaling in health and disease","volume":"95","author":"Lu","year":"2017","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib414","doi-asserted-by":"crossref","first-page":"207","DOI":"10.31887\/DCNS.2020.22.3\/blutz","article-title":"Neurobiology of cannabinoid receptor signaling","volume":"22","author":"Lutz","year":"2020","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1124\/pharmrev.122.000600_bib415","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.02157-18","article-title":"The glycine lipids of Bacteroides thetaiotaomicron are important for fitness during growth in vivo and in vitro","volume":"85","author":"Lynch","year":"2019","journal-title":"Appl Environ Microbiol"},{"key":"10.1124\/pharmrev.122.000600_bib416","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0022-3565(25)38654-4","article-title":"Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids","volume":"268","author":"Lynn","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.122.000600_bib417","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3389\/fnmol.2017.00166","article-title":"Metabolism of the endocannabinoid anandamide: open questions after 25 years","volume":"10","author":"Maccarrone","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"10.1124\/pharmrev.122.000600_bib418","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.molmed.2019.11.002","article-title":"Missing pieces to the endocannabinoid puzzle","volume":"26","author":"Maccarrone","year":"2020","journal-title":"Trends Mol Med"},{"key":"10.1124\/pharmrev.122.000600_bib419","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.3390\/molecules28062622","article-title":"Deciphering complex interactions in bioactive lipid signaling","volume":"28","author":"Maccarrone","year":"2023","journal-title":"Molecules"},{"key":"10.1124\/pharmrev.122.000600_bib420","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.tips.2015.02.008","article-title":"Endocannabinoid signaling at the periphery: 50 years after THC","volume":"36","author":"Maccarrone","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/pharmrev.122.000600_bib421","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1182\/blood-2002-05-1444","article-title":"Estrogen stimulates arachidonoylethanolamide release from human endothelial cells and platelet activation","volume":"100","author":"Maccarrone","year":"2002","journal-title":"Blood"},{"key":"10.1124\/pharmrev.122.000600_bib422","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.tibs.2010.05.008","article-title":"Intracellular trafficking of anandamide: new concepts for signaling","volume":"35","author":"Maccarrone","year":"2010","journal-title":"Trends Biochem Sci"},{"key":"10.1124\/pharmrev.122.000600_bib423","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1471-4159.2009.05948.x","article-title":"Lipid rafts regulate 2-arachidonoylglycerol metabolism and physiological activity in the striatum","volume":"109","author":"Maccarrone","year":"2009","journal-title":"J Neurochem"},{"key":"10.1124\/pharmrev.122.000600_bib424","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0014-5793(00)01223-0","article-title":"Human mast cells take up and hydrolyze anandamide under the control of 5-lipoxygenase and do not express cannabinoid receptors","volume":"468","author":"Maccarrone","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1124\/pharmrev.122.000600_bib425","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nrn3846","article-title":"Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies","volume":"15","author":"Maccarrone","year":"2014","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/pharmrev.122.000600_bib426","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/17512433.2017.1292849","article-title":"Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others?","volume":"10","author":"Maccarrone","year":"2017","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib427","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41585-020-00391-8","article-title":"Cannabinoid signalling and effects of cannabis on the male reproductive system","volume":"18","author":"Maccarrone","year":"2021","journal-title":"Nat Rev Urol"},{"key":"10.1124\/pharmrev.122.000600_bib428","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/nn2042","article-title":"Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum","volume":"11","author":"Maccarrone","year":"2008","journal-title":"Nat Neurosci"},{"key":"10.1124\/pharmrev.122.000600_bib429","doi-asserted-by":"crossref","first-page":"32332","DOI":"10.1074\/jbc.273.48.32332","article-title":"Anandamide hydrolysis by human cells in culture and brain","volume":"273","author":"Maccarrone","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000600_bib430","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/3-540-26573-2_10","article-title":"Distribution of cannabinoid receptors in the central and peripheral nervous system","volume":"168","author":"Mackie","year":"2005","journal-title":"Handb Exp Pharmacol"},{"issue":"1-2, Suppl 1","key":"10.1124\/pharmrev.122.000600_bib431","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.mce.2008.01.022","article-title":"Signaling via CNS cannabinoid receptors","volume":"286","author":"Mackie","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"10.1124\/pharmrev.122.000600_bib432","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/cmdc.202000153","article-title":"Synthesis and biological evaluation of endocannabinoid uptake inhibitors derived from WOBE437","volume":"16","author":"M\u00e4der","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1124\/pharmrev.122.000600_bib433","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.str.2014.12.018","article-title":"Structure of human N-acylphosphatidylethanolamine-hydrolyzing phospholipase D: regulation of fatty acid ethanolamide biosynthesis by bile acids","volume":"23","author":"Magotti","year":"2015","journal-title":"Structure"},{"issue":"Suppl 1","key":"10.1124\/pharmrev.122.000600_bib434","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/j.pain.2013.03.023","article-title":"Endocannabinoids: a unique opportunity to develop multitarget analgesics","volume":"154","author":"Maione","year":"2013","journal-title":"Pain"},{"key":"10.1124\/pharmrev.122.000600_bib435","doi-asserted-by":"crossref","first-page":"115195","DOI":"10.1016\/j.bmc.2019.115195","article-title":"Design and synthesis of cyanamides as potent and selective N-acylethanolamine acid amidase inhibitors","volume":"28","author":"Malamas","year":"2020","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib436","doi-asserted-by":"crossref","first-page":"G9","DOI":"10.1152\/ajpgi.00467.2007","article-title":"Endocannabinoids and liver disease. I. Endocannabinoids and their receptors in the liver","volume":"294","author":"Mallat","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/pharmrev.122.000600_bib437","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1021\/acs.jproteome.7b00023","article-title":"Binding site characterization of AM1336, a novel covalent inverse agonist at human cannabinoid 2 receptor, using mass spectrometric analysis","volume":"16","author":"Mallipeddi","year":"2017","journal-title":"J Proteome Res"},{"key":"10.1124\/pharmrev.122.000600_bib438","doi-asserted-by":"crossref","first-page":"158786","DOI":"10.1016\/j.bbalip.2020.158786","article-title":"Alterations of brain endocannabinoidome signaling in germ-free mice","volume":"1865","author":"Manca","year":"2020","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1124\/pharmrev.122.000600_bib439","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1194\/jlr.RA119000424","article-title":"Germ-free mice exhibit profound gut microbiota-dependent alterations of intestinal endocannabinoidome signaling","volume":"61","author":"Manca","year":"2020","journal-title":"J Lipid Res"},{"key":"10.1124\/pharmrev.122.000600_bib440","doi-asserted-by":"crossref","first-page":"108611","DOI":"10.1016\/j.neuropharm.2021.108611","article-title":"Pharmacological selection of cannabinoid receptor effectors: signalling, allosteric modulation and bias","volume":"193","author":"Manning","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1124\/pharmrev.122.000600_bib441","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1369\/0022155414530995","article-title":"Validating antibodies to the cannabinoid CB2 receptor: antibody sensitivity is not evidence of antibody specificity","volume":"62","author":"Marchalant","year":"2014","journal-title":"J Histochem Cytochem"},{"key":"10.1124\/pharmrev.122.000600_bib442","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/nn.2601","article-title":"The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors","volume":"13","author":"Marrs","year":"2010","journal-title":"Nat Neurosci"},{"issue":"3, Suppl","key":"10.1124\/pharmrev.122.000600_bib443","first-page":"27","article-title":"Neuromodulatory functions of the endocannabinoid system","volume":"29","author":"Marsicano","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"10.1124\/pharmrev.122.000600_bib444","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/mol.117.108605","article-title":"A novel selective inverse agonist of the CB2 receptor as a radiolabeled tool compound for kinetic binding studies","volume":"92","author":"Martella","year":"2017","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib445","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0306-4522(98)00052-9","article-title":"Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice","volume":"85","author":"Martellotta","year":"1998","journal-title":"Neuroscience"},{"key":"10.1124\/pharmrev.122.000600_bib447","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/jnc.13890","article-title":"Fabp1 gene ablation inhibits high-fat diet-induced increase in brain endocannabinoids","volume":"140","author":"Martin","year":"2017","journal-title":"J Neurochem"},{"key":"10.1124\/pharmrev.122.000600_bib448","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/lipd.12192","article-title":"Sterol carrier protein-2\/sterol carrier protein-x\/fatty acid binding protein-1 ablation impacts response of brain endocannabinoid to high-fat diet","volume":"54","author":"Martin","year":"2019","journal-title":"Lipids"},{"key":"10.1124\/pharmrev.122.000600_bib449","doi-asserted-by":"crossref","first-page":"6896","DOI":"10.1002\/anie.201200467","article-title":"Chemical probes for the recognition of cannabinoid receptors in native systems","volume":"51","author":"Mart\u00edn-Couce","year":"2012","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1124\/pharmrev.122.000600_bib450","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3389\/fphar.2017.00744","article-title":"Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2 receptors","volume":"8","author":"Mart\u00ednez-Pinilla","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib451","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1471-4159.2007.05073.x","article-title":"5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid","volume":"104","author":"Massi","year":"2008","journal-title":"J Neurochem"},{"key":"10.1124\/pharmrev.122.000600_bib452","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0031-6997(24)01414-5","article-title":"Neurotransmitter transporters in the central nervous system","volume":"51","author":"Masson","year":"1999","journal-title":"Pharmacol Rev"},{"key":"10.1124\/pharmrev.122.000600_bib453","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.phrs.2013.06.001","article-title":"NESS06SM reduces body weight with an improved profile relative to SR141716A","volume":"74","author":"Mastinu","year":"2013","journal-title":"Pharmacol Res"},{"key":"10.1124\/pharmrev.122.000600_bib454","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"10.1124\/pharmrev.122.000600_bib455","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0006-8993(03)03376-6","article-title":"Neuroprotective and brain edema-reducing efficacy of the novel cannabinoid receptor agonist BAY 38-7271","volume":"989","author":"Mauler","year":"2003","journal-title":"Brain Res"},{"key":"10.1124\/pharmrev.122.000600_bib456","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1124\/jpet.302.1.359","article-title":"Characterization of the diarylether sulfonylester (-)-(R)-3-(2-hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate (BAY 38-7271) as a potent cannabinoid receptor agonist with neuroprotective properties","volume":"302","author":"Mauler","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl A","key":"10.1124\/pharmrev.122.000600_bib457","first-page":"15A","article-title":"Pharmacokinetics of cannabinoids","volume":"10","author":"McGilveray","year":"2005","journal-title":"Pain Res Manag"},{"key":"10.1124\/pharmrev.122.000600_bib458","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev.biochem.74.082803.133450","article-title":"Structure and function of fatty acid amide hydrolase","volume":"74","author":"McKinney","year":"2005","journal-title":"Annu Rev Biochem"},{"key":"10.1124\/pharmrev.122.000600_bib459","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/bph.12944","article-title":"Are cannabidiol and \u0394(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review","volume":"172","author":"McPartland","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib460","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.biopsych.2017.09.024","article-title":"Stress promotes drug seeking through glucocorticoid-dependent endocannabinoid mobilization in the prelimbic cortex","volume":"84","author":"McReynolds","year":"2018","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pharmrev.122.000600_bib461","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/sj.bjp.0706415","article-title":"Plant cannabinoids: a neglected pharmacological treasure trove","volume":"146","author":"Mechoulam","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib462","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-pharmtox-051921-083709","article-title":"A delightful trip along the pathway of cannabinoid and endocannabinoid chemistry and pharmacology","volume":"63","author":"Mechoulam","year":"2023","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/pharmrev.122.000600_bib463","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0040-4039(00)90646-4","article-title":"The absolute configuration of delta-1-tetrahydrocannabinol, the major active constituent of hashish","volume":"12","author":"Mechoulam","year":"1967","journal-title":"Tetrahedron Lett"},{"key":"10.1124\/pharmrev.122.000600_bib464","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","article-title":"Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors","volume":"50","author":"Mechoulam","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib465","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0079-6468(08)70037-7","article-title":"Towards cannabinoid drugs--revisited","volume":"35","author":"Mechoulam","year":"1998","journal-title":"Prog Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib466","doi-asserted-by":"crossref","first-page":"15645","DOI":"10.1038\/s41598-017-15154-6","article-title":"Blockade of CB1 cannabinoid receptor alters gut microbiota and attenuates inflammation and diet-induced obesity","volume":"7","author":"Mehrpouya-Bahrami","year":"2017","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.122.000600_bib467","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1523\/JNEUROSCI.4503-03.2004","article-title":"Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors","volume":"24","author":"Melis","year":"2004","journal-title":"J Neurosci"},{"key":"10.1124\/pharmrev.122.000600_bib468","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0026-895X(25)13256-2","article-title":"Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: studies of bicyclic cannabinoid analogs","volume":"44","author":"Melvin","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib469","first-page":"155","article-title":"Structure-activity relationships defining the ACD-tricyclic cannabinoids: cannabinoid receptor binding and analgesic activity","volume":"13","author":"Melvin","year":"1995","journal-title":"Drug Des Discov"},{"key":"10.1124\/pharmrev.122.000600_bib470","doi-asserted-by":"crossref","first-page":"11193","DOI":"10.1002\/anie.201603746","article-title":"Second\u2010generation non\u2010covalent NAAA inhibitors are protective in a model of multiple sclerosis","volume":"55","author":"Migliore","year":"2016","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1124\/pharmrev.122.000600_bib471","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jmb.2010.05.034","article-title":"Crystal structure of fatty acid amide hydrolase bound to the carbamate inhibitor URB597: discovery of a deacylating water molecule and insight into enzyme inactivation","volume":"400","author":"Mileni","year":"2010","journal-title":"J Mol Biol"},{"key":"10.1124\/pharmrev.122.000600_bib472","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1073\/pnas.0510676103","article-title":"N-arachidonoyl L-serine, an endocannabinoid-like brain constituent with vasodilatory properties","volume":"103","author":"Milman","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000600_bib473","doi-asserted-by":"crossref","first-page":"7469","DOI":"10.1007\/s00018-021-04002-6","article-title":"Hypothalamic endocannabinoids in obesity: an old story with new challenges","volume":"78","author":"Miralpeix","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"10.1124\/pharmrev.122.000600_bib474","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1111\/bph.15842","article-title":"Inhibition of human recombinant T-type calcium channels by phytocannabinoids in vitro","volume":"179","author":"Mirlohi","year":"2022","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib475","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cmet.2018.09.014","article-title":"Mast cell-derived histamine regulates liver ketogenesis via oleoylethanolamide signaling","volume":"29","author":"Misto","year":"2019","journal-title":"Cell Metab"},{"key":"10.1124\/pharmrev.122.000600_bib476","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41589-020-0528-7","article-title":"Discovery of a NAPE-PLD inhibitor that modulates emotional behavior in mice","volume":"16","author":"Mock","year":"2020","journal-title":"Nat Chem Biol"},{"key":"10.1124\/pharmrev.122.000600_bib477","doi-asserted-by":"crossref","first-page":"17852","DOI":"10.1073\/pnas.0507470102","article-title":"Identification of a high-affinity binding site involved in the transport of endocannabinoids","volume":"102","author":"Moore","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000600_bib478","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1021\/jm031140x","article-title":"Cyclohexylcarbamic acid 3\u2032- or 4\u2032-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies","volume":"47","author":"Mor","year":"2004","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib479","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/can.2017.0036","article-title":"An update on non-CB1, non-CB2 cannabinoid related G-protein-coupled receptors","volume":"2","author":"Morales","year":"2017","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1124\/pharmrev.122.000600_bib480","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1080\/13543776.2016.1193157","article-title":"Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent update","volume":"26","author":"Morales","year":"2016","journal-title":"Expert Opin Ther Pat"},{"key":"10.1124\/pharmrev.122.000600_bib481","first-page":"103","article-title":"Molecular targets of the phytocannabinoids: a complex picture","volume":"103","author":"Morales","year":"2017","journal-title":"Prog Chem Org Nat Prod"},{"key":"10.1124\/pharmrev.122.000600_bib482","doi-asserted-by":"crossref","first-page":"14216","DOI":"10.1021\/acs.jmedchem.0c00926","article-title":"Therapeutic exploitation of GPR18: beyond the cannabinoids?","volume":"63","author":"Morales","year":"2020","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib483","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/msb.2010.46","article-title":"The endocannabinoid system links gut microbiota to adipogenesis","volume":"6","author":"Muccioli","year":"2010","journal-title":"Mol Syst Biol"},{"key":"10.1124\/pharmrev.122.000600_bib484","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/bph.13338","article-title":"The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity","volume":"173","author":"Mukhopadhyay","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib485","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1476-5381.2010.00769.x","article-title":"CB1 cannabinoid receptors promote oxidative\/nitrosative stress, inflammation and cell death in a murine nephropathy model","volume":"160","author":"Mukhopadhyay","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib486","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.freeradbiomed.2009.11.022","article-title":"Cannabinoid-2 receptor limits inflammation, oxidative\/nitrosative stress, and cell death in nephropathy","volume":"48","author":"Mukhopadhyay","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"10.1124\/pharmrev.122.000600_bib487","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0009-3084(02)00153-6","article-title":"CB(1) cannabinoid receptor-G protein association: a possible mechanism for differential signaling","volume":"121","author":"Mukhopadhyay","year":"2002","journal-title":"Chem Phys Lipids"},{"key":"10.1124\/pharmrev.122.000600_bib488","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3389\/fnmol.2018.00487","article-title":"Cannabinoid ligands targeting TRP channels","volume":"11","author":"Muller","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"10.1124\/pharmrev.122.000600_bib489","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1002\/mds.28681","article-title":"Monoacylglycerol lipase inhibition in Tourette syndrome: a 12-week, randomized, controlled study","volume":"36","author":"M\u00fcller-Vahl","year":"2021","journal-title":"Mov Disord"},{"key":"10.1124\/pharmrev.122.000600_bib490","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1055\/a-1675-3494","article-title":"Endocannabinoid modulation using monoacylglycerol lipase inhibition in Tourette syndrome: a phase 1 randomized, placebo-controlled study","volume":"55","author":"M\u00fcller-Vahl","year":"2022","journal-title":"Pharmacopsychiatry"},{"key":"10.1124\/pharmrev.122.000600_bib491","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"10.1124\/pharmrev.122.000600_bib492","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.physbeh.2012.11.007","article-title":"The administration of endocannabinoid uptake inhibitors OMDM-2 or VDM-11 promotes sleep and decreases extracellular levels of dopamine in rats","volume":"109","author":"Murillo-Rodr\u00edguez","year":"2013","journal-title":"Physiol Behav"},{"key":"10.1124\/pharmrev.122.000600_bib493","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0306-4522(03)00126-X","article-title":"Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation","volume":"119","author":"Nackley","year":"2003","journal-title":"Neuroscience"},{"key":"10.1124\/pharmrev.122.000600_bib494","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.3390\/ijms20092109","article-title":"Role of cannabinoid receptor type 1 in insulin resistance and its biological implications","volume":"20","author":"Nagappan","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.122.000600_bib495","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/bjp.2008.340","article-title":"MDA7: a novel selective agonist for CB2 receptors that prevents allodynia in rat neuropathic pain models","volume":"155","author":"Naguib","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib496","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.47209","article-title":"Cocaine-induced endocannabinoid signaling mediated by sigma-1 receptors and extracellular vesicle secretion","volume":"8","author":"Nakamura","year":"2019","journal-title":"eLife"},{"key":"10.1124\/pharmrev.122.000600_bib497","series-title":"The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research","year":"2017"},{"key":"10.1124\/pharmrev.122.000600_bib498","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12974-018-1103-y","article-title":"Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy","volume":"15","author":"Navarrete","year":"2018","journal-title":"J Neuroinflammation"},{"key":"10.1124\/pharmrev.122.000600_bib499","doi-asserted-by":"crossref","first-page":"104940","DOI":"10.1016\/j.phrs.2020.104940","article-title":"Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB1, CB2 and CB1\/CB2 heteromer receptors","volume":"159","author":"Navarro","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1124\/pharmrev.122.000600_bib500","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/cmdc.201500218","article-title":"Novel triazolopyrimidine-derived cannabinoid receptor 2 agonists as potential treatment for inflammatory kidney diseases","volume":"11","author":"Nettekoven","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1124\/pharmrev.122.000600_bib501","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.bmcl.2013.01.044","article-title":"Highly potent and selective cannabinoid receptor 2 agonists: initial hit optimization of an adamantyl hit series identified from high-through-put screening","volume":"23","author":"Nettekoven","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pharmrev.122.000600_bib502","first-page":"1","article-title":"Identification and characterization of potent and selective inhibitors of endocannabinoid uptake","volume":"14","author":"Nicolussi","year":"2014","journal-title":"GCB Grad Sch Univ Bern, Switz"},{"key":"10.1124\/pharmrev.122.000600_bib503","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/bs.vh.2014.12.011","article-title":"Endocannabinoid transport revisited","volume":"98","author":"Nicolussi","year":"2015","journal-title":"Vitam Horm"},{"key":"10.1124\/pharmrev.122.000600_bib504","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.bcp.2014.09.020","article-title":"Correlating FAAH and anandamide cellular uptake inhibition using N-alkylcarbamate inhibitors: from ultrapotent to hyperpotent","volume":"92","author":"Nicolussi","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib505","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.phrs.2013.12.010","article-title":"Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB\/c mice","volume":"80","author":"Nicolussi","year":"2014","journal-title":"Pharmacol Res"},{"key":"10.1124\/pharmrev.122.000600_bib506","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1021\/cn400116z","article-title":"Evaluation of NHS carbamates as a potent and selective class of endocannabinoid hydrolase inhibitors","volume":"4","author":"Niphakis","year":"2013","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/pharmrev.122.000600_bib507","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cell.2009.11.027","article-title":"Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis","volume":"140","author":"Nomura","year":"2010","journal-title":"Cell"},{"key":"10.1124\/pharmrev.122.000600_bib508","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1126\/science.1209200","article-title":"Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation","volume":"334","author":"Nomura","year":"2011","journal-title":"Science"},{"key":"10.1124\/pharmrev.122.000600_bib509","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/bph.12360","article-title":"Anandamide transport inhibition by ARN272 attenuates nausea-induced behaviour in rats, and vomiting in shrews (Suncus murinus)","volume":"170","author":"O\u2019Brien","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib510","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/bph.13497","article-title":"An update on PPAR activation by cannabinoids","volume":"173","author":"O\u2019Sullivan","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib511","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1016\/j.bmcl.2012.02.072","article-title":"Discovery of S-777469: an orally available CB2 agonist as an antipruritic agent","volume":"22","author":"Odan","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pharmrev.122.000600_bib512","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1194\/jlr.D004176","article-title":"Pitfalls and solutions in assaying anandamide transport in cells","volume":"51","author":"Oddi","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1124\/pharmrev.122.000600_bib513","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.chembiol.2009.05.004","article-title":"Molecular identification of albumin and Hsp70 as cytosolic anandamide-binding proteins","volume":"16","author":"Oddi","year":"2009","journal-title":"Chem Biol"},{"key":"10.1124\/pharmrev.122.000600_bib514","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s00018-008-7494-7","article-title":"Evidence for the intracellular accumulation of anandamide in adiposomes","volume":"65","author":"Oddi","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.1124\/pharmrev.122.000600_bib515","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.coph.2019.11.002","article-title":"Endocannabinoid system and adult neurogenesis: a focused review","volume":"50","author":"Oddi","year":"2020","journal-title":"Curr Opin Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib516","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.bbalip.2017.02.004","article-title":"Palmitoylation of cysteine 415 of CB1 receptor affects ligand-stimulated internalization and selective interaction with membrane cholesterol and caveolin 1","volume":"1862","author":"Oddi","year":"2017","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1124\/pharmrev.122.000600_bib517","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1073\/pnas.0504187103","article-title":"Peripheral cannabinoid receptor, CB2, regulates bone mass","volume":"103","author":"Ofek","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000600_bib518","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1073\/pnas.1522364112","article-title":"Rapid and profound rewiring of brain lipid signaling networks by acute diacylglycerol lipase inhibition","volume":"113","author":"Ogasawara","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000600_bib519","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nchembio.2127","article-title":"A calcium-dependent acyltransferase that produces N-acyl phosphatidylethanolamines","volume":"12","author":"Ogura","year":"2016","journal-title":"Nat Chem Biol"},{"key":"10.1124\/pharmrev.122.000600_bib520","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.1016\/j.bmcl.2007.09.004","article-title":"N-Alkylidenearylcarboxamides as new potent and selective CB(2) cannabinoid receptor agonists with good oral bioavailability","volume":"17","author":"Ohta","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pharmrev.122.000600_bib521","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.1074\/jbc.M306642200","article-title":"Molecular characterization of a phospholipase D generating anandamide and its congeners","volume":"279","author":"Okamoto","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000600_bib522","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejmech.2007.02.023","article-title":"Carbamoyl tetrazoles as inhibitors of endocannabinoid inactivation: a critical revisitation","volume":"43","author":"Ortar","year":"2008","journal-title":"Eur J Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib523","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/S0006-2952(03)00109-6","article-title":"Novel selective and metabolically stable inhibitors of anandamide cellular uptake","volume":"65","author":"Ortar","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib524","doi-asserted-by":"crossref","first-page":"8184","DOI":"10.1021\/bi049395f","article-title":"Comparison of anandamide transport in FAAH wild-type and knockout neurons: evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake","volume":"43","author":"Ortega-Guti\u00e9rrez","year":"2004","journal-title":"Biochemistry"},{"key":"10.1124\/pharmrev.122.000600_bib525","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.3389\/fphar.2018.01202","article-title":"Cannabinoid receptor 2 signalling bias elicited by 2,4,6-trisubstituted 1,3,5-triazines","volume":"9","author":"Oyagawa","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib526","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/febs.12260","article-title":"Modulating the endocannabinoid system in human health and disease--successes and failures","volume":"280","author":"Pacher","year":"2013","journal-title":"FEBS J"},{"key":"10.1124\/pharmrev.122.000600_bib527","doi-asserted-by":"crossref","first-page":"G850","DOI":"10.1152\/ajpgi.00523.2007","article-title":"Endocannabinoids and liver disease. III. Endocannabinoid effects on immune cells: implications for inflammatory liver diseases","volume":"294","author":"Pacher","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/pharmrev.122.000600_bib528","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/sj.bjp.0707582","article-title":"Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning","volume":"153","author":"Pacher","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib529","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.plipres.2011.01.001","article-title":"Is lipid signaling through cannabinoid 2 receptors part of a protective system?","volume":"50","author":"Pacher","year":"2011","journal-title":"Prog Lipid Res"},{"key":"10.1124\/pharmrev.122.000600_bib530","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","article-title":"The endocannabinoid system as an emerging target of pharmacotherapy","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol Rev"},{"key":"10.1124\/pharmrev.122.000600_bib531","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1146\/annurev-pharmtox-010818-021441","article-title":"Beyond THC and Endocannabinoids","volume":"60","author":"Pacher","year":"2020","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/pharmrev.122.000600_bib532","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/HYPERTENSIONAHA.105.063651","article-title":"Modulation of the endocannabinoid system in cardiovascular disease: therapeutic potential and limitations","volume":"52","author":"Pacher","year":"2008","journal-title":"Hypertension"},{"key":"10.1124\/pharmrev.122.000600_bib533","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.phytochem.2014.11.012","article-title":"Truffles contain endocannabinoid metabolic enzymes and anandamide","volume":"110","author":"Pacioni","year":"2015","journal-title":"Phytochemistry"},{"key":"10.1124\/pharmrev.122.000600_bib534","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.3390\/cells11162582","article-title":"Expression of functional cannabinoid type-1 (CB1) receptor in mitochondria of white adipocytes","volume":"11","author":"Pagano Zottola","year":"2022","journal-title":"Cells"},{"key":"10.1124\/pharmrev.122.000600_bib535","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1016\/j.bmcl.2008.05.073","article-title":"Novel benzimidazole derivatives as selective CB2 agonists","volume":"18","author":"Pag\u00e9","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pharmrev.122.000600_bib536","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2174\/157018010790596669","article-title":"5-Sulfonamide benzimidazoles: a class of cannabinoid receptors agonists with potent in vivo antinociception activity","volume":"7","author":"Pag\u00e9","year":"2010","journal-title":"Lett Drug Des Discov"},{"key":"10.1124\/pharmrev.122.000600_bib537","doi-asserted-by":"crossref","first-page":"106338","DOI":"10.1016\/j.phrs.2022.106338","article-title":"Targeting NAAA counters dopamine neuron loss and symptom progression in mouse models of parkinsonism","volume":"182","author":"Palese","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1124\/pharmrev.122.000600_bib538","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1080\/07391102.2019.1567384","article-title":"Negative allosteric modulators of cannabinoid receptor 2: protein modeling, binding site identification and molecular dynamics simulations in the presence of an orthosteric agonist","volume":"38","author":"Pandey","year":"2020","journal-title":"J Biomol Struct Dyn"},{"key":"10.1124\/pharmrev.122.000600_bib539","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1111\/j.1476-5381.2010.01176.x","article-title":"Regulation of nausea and vomiting by cannabinoids","volume":"163","author":"Parker","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"Pt A","key":"10.1124\/pharmrev.122.000600_bib540","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neubiorev.2016.12.033","article-title":"The endocannabinoid system as a target for novel anxiolytic drugs","volume":"76","author":"Patel","year":"2017","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1124\/pharmrev.122.000600_bib541","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/s41386-020-00936-w","article-title":"The effects of FAAH inhibition on the neural basis of anxiety-related processing in healthy male subjects: a randomized clinical trial","volume":"46","author":"Paulus","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pharmrev.122.000600_bib542","doi-asserted-by":"crossref","DOI":"10.1177\/1744806917697007","article-title":"Fatty-acid-binding protein inhibition produces analgesic effects through peripheral and central mechanisms","volume":"13","author":"Peng","year":"2017","journal-title":"Mol Pain"},{"key":"10.1124\/pharmrev.122.000600_bib543","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2174\/0929867306666220401124036","article-title":"Pharmacology of cannabinoid receptor ligands","volume":"6","author":"Pertwee","year":"1999","journal-title":"Curr Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib544","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/gut.48.6.859","article-title":"Cannabinoids and the gastrointestinal tract","volume":"48","author":"Pertwee","year":"2001","journal-title":"Gut"},{"key":"10.1124\/pharmrev.122.000600_bib545","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0163-7258(02)00255-3","article-title":"Cannabinoids and multiple sclerosis","volume":"95","author":"Pertwee","year":"2002","journal-title":"Pharmacol Ther"},{"key":"10.1124\/pharmrev.122.000600_bib546","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.lfs.2004.10.025","article-title":"Inverse agonism and neutral antagonism at cannabinoid CB1 receptors","volume":"76","author":"Pertwee","year":"2005","journal-title":"Life Sci"},{"key":"10.1124\/pharmrev.122.000600_bib547","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib548","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1369-1600.2008.00108.x","article-title":"Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond","volume":"13","author":"Pertwee","year":"2008","journal-title":"Addict Biol"},{"key":"10.1124\/pharmrev.122.000600_bib549","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1098\/rstb.2011.0381","article-title":"Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities","volume":"367","author":"Pertwee","year":"2012","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1124\/pharmrev.122.000600_bib550","series-title":"Handbook of Cannabis","author":"Pertwee","year":"2014"},{"key":"10.1124\/pharmrev.122.000600_bib551","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacol Rev"},{"key":"10.1124\/pharmrev.122.000600_bib552","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/bph.14073","article-title":"Cannabidiolic acid methyl ester, a stable synthetic analogue of cannabidiolic acid, can produce 5-HT1A receptor-mediated suppression of nausea and anxiety in rats","volume":"175","author":"Pertwee","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib553","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/j.1476-5381.1992.tb09088.x","article-title":"Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine","volume":"105","author":"Pertwee","year":"1992","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib554","doi-asserted-by":"crossref","first-page":"PL1","DOI":"10.1016\/S0024-3205(98)00238-0","article-title":"Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of delta9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors","volume":"63","author":"Petitet","year":"1998","journal-title":"Life Sci"},{"key":"10.1124\/pharmrev.122.000600_bib555","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/00001756-199602290-00026","article-title":"Biochemical and pharmacological characterization of cannabinoid binding sites using [3H]SR141716A","volume":"7","author":"Petitet","year":"1996","journal-title":"Neuroreport"},{"key":"10.1124\/pharmrev.122.000600_bib556","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/bph.13580","article-title":"The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations","volume":"174","author":"Petrosino","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib557","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12974-019-1671-5","article-title":"Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity","volume":"16","author":"Petrosino","year":"2019","journal-title":"J Neuroinflammation"},{"key":"10.1124\/pharmrev.122.000600_bib558","doi-asserted-by":"crossref","first-page":"5859","DOI":"10.1016\/j.bmcl.2011.07.099","article-title":"Design and evaluation of a novel fluorescent CB2 ligand as probe for receptor visualization in immune cells","volume":"21","author":"Petrov","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pharmrev.122.000600_bib559","doi-asserted-by":"crossref","first-page":"9560","DOI":"10.1038\/s41598-017-09808-8","article-title":"Pepcan-12 (RVD-hemopressin) is a CB2 receptor positive allosteric modulator constitutively secreted by adrenals and in liver upon tissue damage","volume":"7","author":"Petrucci","year":"2017","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.122.000600_bib561","unstructured":"Pharma Intelligence (2022) Olorinab. Arena cannabinoid pain compound misses in phase IIb IBS trial. Scrip, informa.com (accessed October 2022)."},{"key":"10.1124\/pharmrev.122.000600_bib563","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.neuron.2017.02.002","article-title":"The CB1 receptor as the cornerstone of exostasis","volume":"93","author":"Piazza","year":"2017","journal-title":"Neuron"},{"key":"10.1124\/pharmrev.122.000600_bib564","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrn1247","article-title":"The molecular logic of endocannabinoid signalling","volume":"4","author":"Piomelli","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/pharmrev.122.000600_bib565","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev-pharmtox-052220-021800","article-title":"Endocannabinoid-based therapies","volume":"62","author":"Piomelli","year":"2022","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/pharmrev.122.000600_bib566","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1073\/pnas.96.10.5802","article-title":"Structural determinants for recognition and translocation by the anandamide transporter","volume":"96","author":"Piomelli","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000600_bib567","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.1021\/acs.jmedchem.0c00191","article-title":"N-acylethanolamine acid amidase (NAAA): structure, function, and inhibition","volume":"63","author":"Piomelli","year":"2020","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib569","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1743-7075-8-51","article-title":"Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice","volume":"8","author":"Piscitelli","year":"2011","journal-title":"Nutr Metab (Lond)"},{"key":"10.1124\/pharmrev.122.000600_bib570","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1021\/acschemneuro.9b00633","article-title":"Protective effects of N-oleoylglycine in a mouse model of mild traumatic brain injury","volume":"11","author":"Piscitelli","year":"2020","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/pharmrev.122.000600_bib571","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0091-3057(91)90385-F","article-title":"Recent clinical experience with dronabinol","volume":"40","author":"Plasse","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pharmrev.122.000600_bib572","doi-asserted-by":"crossref","first-page":"159179","DOI":"10.1016\/j.bbalip.2022.159179","article-title":"Retinol-binding protein 2 (RBP2): More than just dietary retinoid uptake","volume":"1867","author":"Plau","year":"2022","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1124\/pharmrev.122.000600_bib573","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nm.4236","article-title":"A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice","volume":"23","author":"Plovier","year":"2017","journal-title":"Nat Med"},{"key":"10.1124\/pharmrev.122.000600_bib574","doi-asserted-by":"crossref","first-page":"6917","DOI":"10.1021\/jm400739u","article-title":"Synthesis and structure-activity relationship (SAR) of 2-methyl-4-oxo-3-oxetanylcarbamic acid esters, a class of potent N-acylethanolamine acid amidase (NAAA) inhibitors","volume":"56","author":"Ponzano","year":"2013","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib575","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1124\/jpet.301.3.1020","article-title":"Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor","volume":"301","author":"Porter","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.122.000600_bib576","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.3390\/molecules24183338","article-title":"Selective cannabinoid 2 receptor agonists as potential therapeutic drugs for the treatment of endotoxin-induced uveitis","volume":"24","author":"Porter","year":"2019","journal-title":"Molecules"},{"key":"10.1124\/pharmrev.122.000600_bib577","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0022-3565(24)37993-5","article-title":"SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist","volume":"288","author":"Portier","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.122.000600_bib578","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fendo.2015.00086","article-title":"Diacylglycerol lipase \u03b1 knockout mice demonstrate metabolic and behavioral phenotypes similar to those of cannabinoid receptor 1 knockout mice","volume":"6","author":"Powell","year":"2015","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1124\/pharmrev.122.000600_bib579","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.4155\/fmc-2018-0370","article-title":"Labelled chemical probes for demonstrating direct target engagement in living systems","volume":"11","author":"Prevet","year":"2019","journal-title":"Future Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib580","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/bs.apha.2017.03.005","article-title":"Functional selectivity at cannabinoid receptors","volume":"80","author":"Priestley","year":"2017","journal-title":"Adv Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib581","doi-asserted-by":"crossref","first-page":"894960","DOI":"10.3389\/fphar.2022.894960","article-title":"Cannabis for medical use: versatile plant rather than a single drug","volume":"13","author":"Procaccia","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib582","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/978-3-319-20825-1_7","article-title":"Endocannabinoids in multiple sclerosis and amyotrophic lateral sclerosis","volume":"231","author":"Pryce","year":"2015","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib583","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1021\/acs.accounts.2c00521","article-title":"Chemical probes to control and visualize lipid metabolism in the brain","volume":"55","author":"Punt","year":"2023","journal-title":"Acc Chem Res"},{"key":"10.1124\/pharmrev.122.000600_bib584","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1021\/np060598+","article-title":"Self-assembling cannabinomimetics: supramolecular structures of N-alkyl amides","volume":"70","author":"Raduner","year":"2007","journal-title":"J Nat Prod"},{"issue":"12 Pt A","key":"10.1124\/pharmrev.122.000600_bib585","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.bbalip.2016.09.008","article-title":"Calcium-dependent generation of N-acylethanolamines and lysophosphatidic acids by glycerophosphodiesterase GDE7","volume":"1861","author":"Rahman","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pharmrev.122.000600_bib586","doi-asserted-by":"crossref","first-page":"159222","DOI":"10.1016\/j.bbalip.2022.159222","article-title":"Formation of N-acyl-phosphatidylethanolamines by cytosolic phospholipase A2\u03b5 in an ex vivo murine model of brain ischemia","volume":"1867","author":"Rahman","year":"2022","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1124\/pharmrev.122.000600_bib587","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1189\/jlb.0307180","article-title":"Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia\/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis","volume":"82","author":"Rajesh","year":"2007","journal-title":"J Leukoc Biol"},{"key":"10.1124\/pharmrev.122.000600_bib588","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0022-3565(24)35376-5","article-title":"Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells","volume":"292","author":"Rakhshan","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.122.000600_bib589","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.pbb.2010.07.021","article-title":"The novel cannabinoid CB1 antagonist AM6545 suppresses food intake and food-reinforced behavior","volume":"97","author":"Randall","year":"2010","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pharmrev.122.000600_bib590","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/978-1-4939-3539-0_20","article-title":"Assay of endocannabinoid uptake","volume":"1412","author":"Rau","year":"2016","journal-title":"Methods Mol Biol"},{"key":"10.1124\/pharmrev.122.000600_bib591","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0031-6997(25)06863-2","article-title":"Structure-activity relationships in cannabinoids","volume":"38","author":"Razdan","year":"1986","journal-title":"Pharmacol Rev"},{"key":"10.1124\/pharmrev.122.000600_bib592","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0026-895X(25)09587-2","article-title":"Investigation of the role of the phenolic hydroxyl in cannabinoid activity","volume":"38","author":"Reggio","year":"1990","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib593","first-page":"414","article-title":"Small-molecule inhibitors of endocannabinoid transport and trafficking","volume":"76","author":"Reynoso-Moreno","year":"2021","journal-title":"Drug Discov Series"},{"key":"10.1124\/pharmrev.122.000600_bib594","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fnmol.2018.00180","article-title":"The endocannabinoid reuptake inhibitor WOBE437 is orally bioavailable and exerts indirect polypharmacological effects via different endocannabinoid receptors","volume":"11","author":"Reynoso-Moreno","year":"2018","journal-title":"Front Mol Neurosci"},{"key":"10.1124\/pharmrev.122.000600_bib595","doi-asserted-by":"crossref","first-page":"9435","DOI":"10.1021\/acs.jafc.7b02979","article-title":"An endocannabinoid uptake inhibitor from black pepper exerts pronounced anti-inflammatory effects in mice","volume":"65","author":"Reynoso-Moreno","year":"2017","journal-title":"J Agric Food Chem"},{"key":"10.1124\/pharmrev.122.000600_bib596","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/978-1-0716-2728-0_28","article-title":"Assay of endocannabinoid uptake","volume":"2576","author":"Reynoso-Moreno","year":"2023","journal-title":"Methods Mol Biol"},{"key":"10.1124\/pharmrev.122.000600_bib597","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1021\/acsptsci.0c00214","article-title":"Selective endocannabinoid reuptake inhibitor WOBE437 reduces disease progression in a mouse model of multiple sclerosis","volume":"4","author":"Reynoso-Moreno","year":"2021","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1124\/pharmrev.122.000600_bib598","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1021\/acschembio.5b00114","article-title":"A potent systemically active N-acylethanolamine acid amidase inhibitor that suppresses inflammation and human macrophage activation","volume":"10","author":"Ribeiro","year":"2015","journal-title":"ACS Chem Biol"},{"key":"10.1124\/pharmrev.122.000600_bib599","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1517\/13543776.2012.682570","article-title":"Selective cannabinoid receptor 2 modulators: a patent review 2009--present","volume":"22","author":"Riether","year":"2012","journal-title":"Expert Opin Ther Pat"},{"key":"10.1124\/pharmrev.122.000600_bib600","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.bmcl.2014.12.019","article-title":"Selective CB2 receptor agonists. Part 2: structure-activity relationship studies and optimization of proline-based compounds","volume":"25","author":"Riether","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pharmrev.122.000600_bib601","article-title":"Utilisation de composes agonistes du recepteur cb2 humain pour la preparation de medicaments immunomodulateurs, nouveaux composes agonistes du recepteur cb2 et les compositions pharmaceutiques les contenant","author":"Rinaldi","year":"1996","journal-title":"FR Pat"},{"key":"10.1124\/pharmrev.122.000600_bib602","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/0024-3205(95)00174-5","article-title":"Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist","volume":"56","author":"Rinaldi-Carmona","year":"1995","journal-title":"Life Sci"},{"key":"10.1124\/pharmrev.122.000600_bib603","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0022-3565(24)37266-0","article-title":"SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor","volume":"284","author":"Rinaldi-Carmona","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.122.000600_bib604","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/apt.12800","article-title":"Lactobacillus acidophilus NCFM affects colonic mucosal opioid receptor expression in patients with functional abdominal pain - a randomised clinical study","volume":"40","author":"Ringel-Kulka","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1124\/pharmrev.122.000600_bib605","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1192\/bjp.178.2.107","article-title":"Therapeutic aspects of cannabis and cannabinoids","volume":"178","author":"Robson","year":"2001","journal-title":"Br J Psychiatry"},{"key":"10.1124\/pharmrev.122.000600_bib606","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1089\/can.2021.0041","article-title":"Therapeutic potential of cannabidiol, cannabidiolic acid, and cannabidiolic acid methyl ester as treatments for nausea and vomiting","volume":"6","author":"Rock","year":"2021","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1124\/pharmrev.122.000600_bib607","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/35102582","article-title":"An anorexic lipid mediator regulated by feeding","volume":"414","author":"Rodr\u00edguez de Fonseca","year":"2001","journal-title":"Nature"},{"key":"10.1124\/pharmrev.122.000600_bib608","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1523\/JNEUROSCI.5214-03.2004","article-title":"Disruption of endocannabinoid release and striatal long-term depression by postsynaptic blockade of endocannabinoid membrane transport","volume":"24","author":"Ronesi","year":"2004","journal-title":"J Neurosci"},{"key":"10.1124\/pharmrev.122.000600_bib609","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/sj.bjp.0705467","article-title":"Anandamide and vanilloid TRPV1 receptors","volume":"140","author":"Ross","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib610","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/hep.24440","article-title":"Association of the cannabinoid receptor 2 (CB2) Gln63Arg polymorphism with indices of liver damage in obese children: an alternative way to highlight the CB2 hepatoprotective properties","volume":"54","author":"Rossi","year":"2011","journal-title":"Hepatology"},{"key":"10.1124\/pharmrev.122.000600_bib611","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13717","article-title":"Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical improvement after probiotic administration in dogs with chronic signs of colonic dysmotility without mucosal inflammatory changes","volume":"32","author":"Rossi","year":"2020","journal-title":"Neurogastroenterol Motil"},{"key":"10.1124\/pharmrev.122.000600_bib612","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nm1521","article-title":"Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors","volume":"13","author":"Rousseaux","year":"2007","journal-title":"Nat Med"},{"key":"10.1124\/pharmrev.122.000600_bib613","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.1021\/cr2002799","article-title":"Endocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes P450: cross-talk between the eicosanoid and endocannabinoid signaling pathways","volume":"111","author":"Rouzer","year":"2011","journal-title":"Chem Rev"},{"key":"10.1124\/pharmrev.122.000600_bib614","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/cpt197722185","article-title":"Physiologic disposition of nabilone, a cannabinol derivative, in man","volume":"22","author":"Rubin","year":"1977","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pharmrev.122.000600_bib615","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fnint.2018.00051","article-title":"Cannabis therapeutics and the future of neurology","volume":"12","author":"Russo","year":"2018","journal-title":"Front Integr Nuerosci"},{"key":"10.1124\/pharmrev.122.000600_bib616","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1093\/jxb\/ern260","article-title":"Phytochemical and genetic analyses of ancient cannabis from Central Asia","volume":"59","author":"Russo","year":"2008","journal-title":"J Exp Bot"},{"key":"10.1124\/pharmrev.122.000600_bib617","doi-asserted-by":"crossref","first-page":"9007","DOI":"10.1021\/bi0608008","article-title":"A FAAH-regulated class of N-acyl taurines that activates TRP ion channels","volume":"45","author":"Saghatelian","year":"2006","journal-title":"Biochemistry"},{"key":"10.1124\/pharmrev.122.000600_bib618","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1002\/anie.201708764","article-title":"Multiple binding sites contribute to the mechanism of mixed agonistic and positive allosteric modulators of the cannabinoid CB1 receptor","volume":"57","author":"Saleh","year":"2018","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1124\/pharmrev.122.000600_bib619","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1107\/S1399004713026795","article-title":"Crystallographic study of FABP5 as an intracellular endocannabinoid transporter","volume":"70","author":"Sanson","year":"2014","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1124\/pharmrev.122.000600_bib620","doi-asserted-by":"crossref","first-page":"16953","DOI":"10.1021\/jacs.0c05587","article-title":"Development of high-specificity fluorescent probes to enable cannabinoid type 2 receptor studies in living cells","volume":"142","author":"Sarott","year":"2020","journal-title":"J Am Chem Soc"},{"key":"10.1124\/pharmrev.122.000600_bib621","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.pain.2012.10.018","article-title":"Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models","volume":"154","author":"Sasso","year":"2013","journal-title":"Pain"},{"key":"10.1124\/pharmrev.122.000600_bib622","doi-asserted-by":"crossref","first-page":"E4397","DOI":"10.1073\/pnas.1605578113","article-title":"Endogenous N-acyl taurines regulate skin wound healing","volume":"113","author":"Sasso","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000600_bib623","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jid.2017.07.853","article-title":"The N-acylethanolamine acid amidase inhibitor ARN077 suppresses inflammation and pruritus in a mouse model of allergic dermatitis","volume":"138","author":"Sasso","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1124\/pharmrev.122.000600_bib624","doi-asserted-by":"crossref","first-page":"6897","DOI":"10.3390\/molecules26226897","article-title":"Subsynaptic distribution, lipid raft targeting and G protein-dependent signalling of the type 1 cannabinoid receptor in synaptosomes from the mouse hippocampus and frontal cortex","volume":"26","author":"Saumell-Esnaola","year":"2021","journal-title":"Molecules"},{"key":"10.1124\/pharmrev.122.000600_bib625","first-page":"37","article-title":"Synthesis of phytocannabinoids","volume":"103","author":"Schafroth","year":"2017","journal-title":"Prog Chem Org Nat Prod"},{"key":"10.1124\/pharmrev.122.000600_bib626","doi-asserted-by":"crossref","first-page":"8255","DOI":"10.1021\/acs.jmedchem.8b00734","article-title":"Elongation of the hydrophobic chain as a molecular switch: discovery of capsaicin derivatives and endogenous lipids as potent transient receptor potential vanilloid channel 2 antagonists","volume":"61","author":"Schiano Moriello","year":"2018","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib627","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1038\/npp.2016.27","article-title":"Blockade of nicotine and cannabinoid reinforcement and relapse by a cannabinoid CB1-receptor neutral antagonist AM4113 and inverse agonist rimonabant in squirrel monkeys","volume":"41","author":"Schindler","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pharmrev.122.000600_bib628","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1007\/s00213-016-4211-3","article-title":"Self-administration of the anandamide transport inhibitor AM404 by squirrel monkeys","volume":"233","author":"Schindler","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.122.000600_bib629","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/nn.2616","article-title":"Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system","volume":"13","author":"Schlosburg","year":"2010","journal-title":"Nat Neurosci"},{"key":"10.1124\/pharmrev.122.000600_bib630","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/s41386-020-00888-1","article-title":"The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study","volume":"46","author":"Schmidt","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pharmrev.122.000600_bib631","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.1523\/JNEUROSCI.1353-18.2019","article-title":"Diacylglycerol lipase-alpha regulates hippocampal-dependent learning and memory processes in mice","volume":"39","author":"Schurman","year":"2019","journal-title":"J Neurosci"},{"key":"10.1124\/pharmrev.122.000600_bib632","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/164_2019_298","article-title":"Molecular mechanism and cannabinoid pharmacology","volume":"258","author":"Schurman","year":"2020","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib633","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cmet.2008.08.005","article-title":"The lipid messenger OEA links dietary fat intake to satiety","volume":"8","author":"Schwartz","year":"2008","journal-title":"Cell Metab"},{"key":"10.1124\/pharmrev.122.000600_bib634","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2017.11.032","article-title":"The cannabinoid transporter inhibitor OMDM-2 reduces social interaction: further evidence for transporter-mediated endocannabinoid release","volume":"130","author":"Seillier","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1124\/pharmrev.122.000600_bib635","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.bmcl.2009.10.062","article-title":"Novel sulfamoyl benzamides as selective CB(2) agonists with improved in vitro metabolic stability","volume":"20","author":"Sellitto","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pharmrev.122.000600_bib636","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/nature20613","article-title":"High-resolution crystal structure of the human CB1 cannabinoid receptor","volume":"540","author":"Shao","year":"2016","journal-title":"Nature"},{"key":"10.1124\/pharmrev.122.000600_bib637","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1053\/j.gastro.2016.04.015","article-title":"The role of the endocannabinoid system in the brain-gut axis","volume":"151","author":"Sharkey","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1124\/pharmrev.122.000600_bib638","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3389\/fmicb.2017.00272","article-title":"Anti-obesity effect of capsaicin in mice fed with high-fat diet is associated with an increase in population of the gut bacterium Akkermansia muciniphila","volume":"8","author":"Shen","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1124\/pharmrev.122.000600_bib639","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1021\/acs.molpharmaceut.7b00657","article-title":"Liposomal delivery of diacylglycerol lipase-beta inhibitors to macrophages dramatically enhances selectivity and efficacy in vivo","volume":"15","author":"Shin","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1124\/pharmrev.122.000600_bib640","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.chembiol.2020.01.005","article-title":"DAGL-beta functions as a PUFA-specific triacylglycerol lipase in macrophages","volume":"27","author":"Shin","year":"2020","journal-title":"Cell Chem Biol"},{"key":"10.1124\/pharmrev.122.000600_bib641","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.celrep.2014.11.001","article-title":"Genetic disruption of 2-arachidonoylglycerol synthesis reveals a key role for endocannabinoid signaling in anxiety modulation","volume":"9","author":"Shonesy","year":"2014","journal-title":"Cell Rep"},{"key":"10.1124\/pharmrev.122.000600_bib642","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/jnc.14972","article-title":"Cyclic AMP-dependent protein kinase and D1 dopamine receptors regulate diacylglycerol lipase-\u03b1 and synaptic 2-arachidonoyl glycerol signaling","volume":"153","author":"Shonesy","year":"2020","journal-title":"J Neurochem"},{"key":"10.1124\/pharmrev.122.000600_bib643","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/nn.3353","article-title":"CaMKII regulates diacylglycerol lipase-\u03b1 and striatal endocannabinoid signaling","volume":"16","author":"Shonesy","year":"2013","journal-title":"Nat Neurosci"},{"key":"10.1124\/pharmrev.122.000600_bib644","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fphar.2015.00069","article-title":"The therapeutic potential of orphan GPCRs, GPR35 and GPR55","volume":"6","author":"Shore","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib645","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0022-3565(25)20744-3","article-title":"Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands","volume":"278","author":"Showalter","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.122.000600_bib646","doi-asserted-by":"crossref","first-page":"18150","DOI":"10.1073\/pnas.1113444108","article-title":"The major central endocannabinoid directly acts at GABA(A) receptors","volume":"108","author":"Sigel","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000600_bib647","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12944-021-01609-3","article-title":"(Wh)olistic (e)ndocannabinoidome-microbiome-axis modulation through (n)utrition (WHEN) to curb obesity and related disorders","volume":"21","author":"Sihag","year":"2022","journal-title":"Lipids Health Dis"},{"key":"10.1124\/pharmrev.122.000600_bib648","doi-asserted-by":"crossref","first-page":"115261","DOI":"10.1016\/j.bcp.2022.115261","article-title":"Biosynthesis and metabolism of endocannabinoids and their congeners from the monoacylglycerol and N-acyl-ethanolamine families","volume":"205","author":"Simard","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib649","doi-asserted-by":"crossref","first-page":"26465","DOI":"10.1074\/jbc.M604660200","article-title":"Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha\/beta-hydrolase 4 in this pathway","volume":"281","author":"Simon","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000600_bib650","doi-asserted-by":"crossref","first-page":"9341","DOI":"10.1074\/jbc.M707807200","article-title":"Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-N-acyl ethanolamine precursors in mouse brain","volume":"283","author":"Simon","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000600_bib651","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1021\/acsmedchemlett.8b00597","article-title":"Chromenopyrazole-based high affinity, selective fluorescent ligands for cannabinoid type 2 receptor","volume":"10","author":"Singh","year":"2019","journal-title":"ACS Med Chem Lett"},{"key":"10.1124\/pharmrev.122.000600_bib652","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/sj.npp.1301476","article-title":"The novel cannabinoid CB1 receptor neutral antagonist AM4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats","volume":"33","author":"Sink","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pharmrev.122.000600_bib653","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.euroneuro.2009.11.002","article-title":"Potential anxiogenic effects of cannabinoid CB1 receptor antagonists\/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142","volume":"20","author":"Sink","year":"2010","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib654","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3390\/biomedicines10030631","article-title":"Anti-microbial activity of phytocannabinoids and endocannabinoids in the light of their physiological and pathophysiological roles","volume":"10","author":"Sionov","year":"2022","journal-title":"Biomedicines"},{"key":"10.1124\/pharmrev.122.000600_bib655","doi-asserted-by":"crossref","first-page":"8394","DOI":"10.1073\/pnas.082235799","article-title":"A missense mutation in human fatty acid amide hydrolase associated with problem drug use","volume":"99","author":"Sipe","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000600_bib656","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1021\/acs.jmedchem.5b00283","article-title":"Discovery of a high affinity and selective pyridine analog as a potential positron emission tomography imaging agent for cannabinoid type 2 receptor","volume":"58","author":"Slavik","year":"2015","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib657","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fnmol.2020.00054","article-title":"Positive allosteric modulation of CB1 cannabinoid receptor signaling enhances morphine antinociception and attenuates morphine tolerance without enhancing morphine-induced dependence or reward","volume":"13","author":"Slivicki","year":"2020","journal-title":"Front Mol Neurosci"},{"key":"10.1124\/pharmrev.122.000600_bib658","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.biopsych.2017.06.032","article-title":"Positive allosteric modulation of cannabinoid receptor type 1 suppresses pathological pain without producing tolerance or dependence","volume":"84","author":"Slivicki","year":"2018","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pharmrev.122.000600_bib659","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0022-3565(25)22356-4","article-title":"The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice","volume":"270","author":"Smith","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.122.000600_bib660","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1124\/mol.108.053439","article-title":"A cytochrome P450-derived epoxygenated metabolite of anandamide is a potent cannabinoid receptor 2-selective agonist","volume":"75","author":"Snider","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib661","doi-asserted-by":"crossref","first-page":"13958","DOI":"10.1038\/ncomms13958","article-title":"Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity","volume":"8","author":"Soethoudt","year":"2017","journal-title":"Nat Commun"},{"key":"10.1124\/pharmrev.122.000600_bib662","doi-asserted-by":"crossref","first-page":"6067","DOI":"10.1021\/jacs.7b11281","article-title":"Selective photoaffinity probe that enables assessment of cannabinoid CB2 receptor expression and ligand engagement in human cells","volume":"140","author":"Soethoudt","year":"2018","journal-title":"J Am Chem Soc"},{"key":"10.1124\/pharmrev.122.000600_bib663","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bcp.2018.03.018","article-title":"Structure-kinetic relationship studies of cannabinoid CB2 receptor agonists reveal substituent-specific lipophilic effects on residence time","volume":"152","author":"Soethoudt","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib664","doi-asserted-by":"crossref","first-page":"20966","DOI":"10.1073\/pnas.0907417106","article-title":"Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation","volume":"106","author":"Solorzano","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000600_bib665","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2174\/1389557516666161004162133","article-title":"Cannabis: a treasure trove or Pandora\u2019s box?","volume":"17","author":"Solymosi","year":"2017","journal-title":"Mini Rev Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib666","doi-asserted-by":"crossref","first-page":"166325","DOI":"10.1016\/j.bbadis.2021.166325","article-title":"Cannabinol modulates neuroprotection and intraocular pressure: a potential multi-target therapeutic intervention for glaucoma","volume":"1868","author":"Somvanshi","year":"2022","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1124\/pharmrev.122.000600_bib667","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1021\/acschemneuro.2c00502","article-title":"Identification of CB1 ligands among drugs, phytochemicals and natural-like compounds: virtual screening and in vitro verification","volume":"13","author":"Stasiulewicz","year":"2022","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/pharmrev.122.000600_bib668","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.neuron.2022.12.022","article-title":"THC and CBD: similarities and differences between siblings","volume":"111","author":"Stella","year":"2023","journal-title":"Neuron"},{"key":"10.1124\/pharmrev.122.000600_bib669","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/bs.irn.2015.09.001","article-title":"Endocannabinoid mechanisms influencing nausea","volume":"125","author":"Sticht","year":"2015","journal-title":"Int Rev Neurobiol"},{"key":"10.1124\/pharmrev.122.000600_bib670","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1365-2982.2010.01478.x","article-title":"Differential effects of CB(1) neutral antagonists and inverse agonists on gastrointestinal motility in mice","volume":"22","author":"Storr","year":"2010","journal-title":"Neurogastroenterol Motil"},{"key":"10.1124\/pharmrev.122.000600_bib671","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.3390\/molecules26175352","article-title":"An evaluation of understudied phytocannabinoids and their effects in two neuronal models","volume":"26","author":"Straiker","year":"2021","journal-title":"Molecules"},{"key":"10.1124\/pharmrev.122.000600_bib672","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","article-title":"2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain","volume":"215","author":"Sugiura","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pharmrev.122.000600_bib673","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1016\/j.bmcl.2006.12.044","article-title":"Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP)","volume":"17","author":"Sulsky","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pharmrev.122.000600_bib674","unstructured":"Sun Y, Alexander SP, Kendall DA, Bennett AJ(2008) Involvement of fatty acid binding proteins in the transport of endocannabinoids to peroxisome proliferator activated receptors, in 18th ICRS Annual Symposium (International Cannabinoid Research Society ed) p 17, Burlington."},{"key":"10.1124\/pharmrev.122.000600_bib675","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.brainres.2011.10.044","article-title":"Cerebroprotective effects of TAK-937, a cannabinoid receptor agonist, on ischemic brain damage in middle cerebral artery occluded rats and non-human primates","volume":"1430","author":"Suzuki","year":"2012","journal-title":"Brain Res"},{"key":"10.1124\/pharmrev.122.000600_bib676","doi-asserted-by":"crossref","first-page":"11199","DOI":"10.1021\/acs.jmedchem.8b01302","article-title":"Aliphatic azides as selective cysteine labeling reagents for integral membrane proteins","volume":"61","author":"Szymanski","year":"2018","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib677","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1021\/pr2005583","article-title":"Mass spectrometry-based proteomics of human cannabinoid receptor 2: covalent cysteine 6.47(257)-ligand interaction affording megagonist receptor activation","volume":"10","author":"Szymanski","year":"2011","journal-title":"J Proteome Res"},{"key":"10.1124\/pharmrev.122.000600_bib678","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2012.07.002","article-title":"Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance","volume":"16","author":"Tam","year":"2012","journal-title":"Cell Metab"},{"key":"10.1124\/pharmrev.122.000600_bib679","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1172\/JCI42551","article-title":"Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity","volume":"120","author":"Tam","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1124\/pharmrev.122.000600_bib680","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.neuron.2010.01.021","article-title":"The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission","volume":"65","author":"Tanimura","year":"2010","journal-title":"Neuron"},{"key":"10.1124\/pharmrev.122.000600_bib681","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1021\/jm021119g","article-title":"Design, synthesis, and structure-activity relationships of alkylcarbamic acid aryl esters, a new class of fatty acid amide hydrolase inhibitors","volume":"46","author":"Tarzia","year":"2003","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib682","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1016\/j.bmc.2014.04.062","article-title":"Ultrapure ajulemic acid has improved CB2 selectivity with reduced CB1 activity","volume":"22","author":"Tepper","year":"2014","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib683","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10822-005-8694-y","article-title":"Virtual computational chemistry laboratory--design and description","volume":"19","author":"Tetko","year":"2005","journal-title":"J Comput Aided Mol Des"},{"key":"10.1124\/pharmrev.122.000600_bib684","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1517\/13543770903436505","article-title":"Latest advances in cannabinoid receptor agonists","volume":"19","author":"Thakur","year":"2009","journal-title":"Expert Opin Ther Pat"},{"key":"10.1124\/pharmrev.122.000600_bib685","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/bph.14440","article-title":"Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors","volume":"176","author":"Tham","year":"2019","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib686","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","article-title":"Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro","volume":"150","author":"Thomas","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib687","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/phar.1709","article-title":"Nabilone for the management of pain","volume":"36","author":"Tsang","year":"2016","journal-title":"Pharmacotherapy"},{"key":"10.1124\/pharmrev.122.000600_bib688","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.bbalip.2011.07.009","article-title":"Enzymatic formation of N-acylethanolamines from N-acylethanolamine plasmalogen through N-acylphosphatidylethanolamine-hydrolyzing phospholipase D-dependent and -independent pathways","volume":"1811","author":"Tsuboi","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pharmrev.122.000600_bib689","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.bbalip.2015.01.002","article-title":"Glycerophosphodiesterase GDE4 as a novel lysophospholipase D: a possible involvement in bioactive N-acylethanolamine biosynthesis","volume":"1851","author":"Tsuboi","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pharmrev.122.000600_bib691","doi-asserted-by":"crossref","first-page":"158972","DOI":"10.1016\/j.bbalip.2021.158972","article-title":"Involvement of acid ceramidase in the degradation of bioactive N-acylethanolamines","volume":"1866","author":"Tsuboi","year":"2021","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1124\/pharmrev.122.000600_bib692","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/cbdv.200790159","article-title":"The N-acylethanolamine-hydrolyzing acid amidase (NAAA)","volume":"4","author":"Tsuboi","year":"2007","journal-title":"Chem Biodivers"},{"key":"10.1124\/pharmrev.122.000600_bib693","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s41232-018-0086-5","article-title":"Endocannabinoids and related N-acylethanolamines: biological activities and metabolism","volume":"38","author":"Tsuboi","year":"2018","journal-title":"Inflamm Regen"},{"key":"10.1124\/pharmrev.122.000600_bib694","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bbalip.2007.03.005","article-title":"Predominant expression of lysosomal N-acylethanolamine-hydrolyzing acid amidase in macrophages revealed by immunochemical studies","volume":"1771","author":"Tsuboi","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pharmrev.122.000600_bib695","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1021\/acs.jmedchem.6b00538","article-title":"Therapeutic potential of fatty acid amide hydrolase, monoacylglycerol lipase, and N-acylethanolamine acid amidase inhibitors","volume":"60","author":"Tuo","year":"2017","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib696","first-page":"61","article-title":"Molecular pharmacology of phytocannabinoids","volume":"103","author":"Turner","year":"2017","journal-title":"Prog Chem Org Nat Prod"},{"key":"10.1124\/pharmrev.122.000600_bib697","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/1440-1681.13238","article-title":"A systematic review of the effects of oleoylethanolamide, a high-affinity endogenous ligand of PPAR-\u03b1, on the management and prevention of obesity","volume":"47","author":"Tutunchi","year":"2020","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1124\/pharmrev.122.000600_bib698","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.plipres.2010.02.003","article-title":"N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA)","volume":"49","author":"Ueda","year":"2010","journal-title":"Prog Lipid Res"},{"key":"10.1124\/pharmrev.122.000600_bib699","doi-asserted-by":"crossref","first-page":"31905","DOI":"10.1074\/jbc.M112.368712","article-title":"Generation of N-acylphosphatidylethanolamine by members of the phospholipase A\/acyltransferase (PLA\/AT) family","volume":"287","author":"Uyama","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000600_bib700","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1002\/1873-3468.12787","article-title":"An involvement of phospholipase A\/acyltransferase family proteins in peroxisome regulation and plasmalogen metabolism","volume":"591","author":"Uyama","year":"2017","journal-title":"FEBS Lett"},{"key":"10.1124\/pharmrev.122.000600_bib701","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1021\/jm020818q","article-title":"Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase","volume":"45","author":"van der Stelt","year":"2002","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib702","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-pharmtox-030220-112741","article-title":"Targeting endocannabinoid signaling: FAAH and MAG lipase inhibitors","volume":"61","author":"van Egmond","year":"2021","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/pharmrev.122.000600_bib703","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/sj.bjp.0706253","article-title":"Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate","volume":"145","author":"Vandevoorde","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib704","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0014-2999(95)00181-J","article-title":"Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide","volume":"278","author":"Varga","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib705","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1523\/JNEUROSCI.23-10-04127.2003","article-title":"Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases","volume":"23","author":"Veldhuis","year":"2003","journal-title":"J Neurosci"},{"key":"10.1124\/pharmrev.122.000600_bib706","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.bbalip.2011.07.008","article-title":"Presence, formation and putative biological activities of N-acyl serotonins, a novel class of fatty-acid derived mediators, in the intestinal tract","volume":"1811","author":"Verhoeckx","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pharmrev.122.000600_bib708","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.12345","article-title":"A chemical proteomic atlas of brain serine hydrolases identifies cell type-specific pathways regulating neuroinflammation","volume":"5","author":"Viader","year":"2016","journal-title":"eLife"},{"key":"10.1124\/pharmrev.122.000600_bib709","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1471-4159.1993.tb03576.x","article-title":"Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase","volume":"61","author":"Vogel","year":"1993","journal-title":"J Neurochem"},{"key":"10.1124\/pharmrev.122.000600_bib710","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.urology.2017.02.029","article-title":"Fatty acid amide hydrolase inhibitor treatment in men with chronic prostatitis\/chronic pelvic pain syndrome: an adaptive double-blind, randomized controlled trial","volume":"103","author":"Wagenlehner","year":"2017","journal-title":"Urology"},{"key":"10.1124\/pharmrev.122.000600_bib711","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.3390\/biom12091244","article-title":"Gut microbiota regulation of AHR signaling in liver disease","volume":"12","author":"Wang","year":"2022","journal-title":"Biomolecules"},{"key":"10.1124\/pharmrev.122.000600_bib712","doi-asserted-by":"crossref","first-page":"12325","DOI":"10.1074\/jbc.M512359200","article-title":"Functional analysis of the purified anandamide-generating phospholipase D as a member of the metallo-beta-lactamase family","volume":"281","author":"Wang","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000600_bib713","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1073\/pnas.0336351100","article-title":"Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice","volume":"100","author":"Wang","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000600_bib714","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/oby.2010.219","article-title":"A common haplotype in NAPEPLD is associated with severe obesity in a Norwegian population-based cohort (the HUNT study)","volume":"19","author":"Wangensteen","year":"2011","journal-title":"Obesity (Silver Spring)"},{"key":"10.1124\/pharmrev.122.000600_bib715","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2165\/00003495-198530020-00002","article-title":"Nabilone. a preliminary review of its pharmacological properties and therapeutic use","volume":"30","author":"Ward","year":"1985","journal-title":"Drugs"},{"key":"10.1124\/pharmrev.122.000600_bib716","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nature01807","article-title":"Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels","volume":"424","author":"Watanabe","year":"2003","journal-title":"Nature"},{"key":"10.1124\/pharmrev.122.000600_bib717","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1248\/bpb.19.1109","article-title":"Inhibition of anandamide amidase activity in mouse brain microsomes by cannabinoids","volume":"19","author":"Watanabe","year":"1996","journal-title":"Biol Pharm Bull"},{"key":"10.1124\/pharmrev.122.000600_bib718","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.lfs.2006.12.032","article-title":"Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes","volume":"80","author":"Watanabe","year":"2007","journal-title":"Life Sci"},{"key":"10.1124\/pharmrev.122.000600_bib719","doi-asserted-by":"crossref","first-page":"106337","DOI":"10.1016\/j.prostaglandins.2019.106337","article-title":"Emerging class of omega-3 fatty acid endocannabinoids & their derivatives","volume":"143","author":"Watson","year":"2019","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1124\/pharmrev.122.000600_bib721","doi-asserted-by":"crossref","first-page":"36569","DOI":"10.1074\/jbc.M606646200","article-title":"A second fatty acid amide hydrolase with variable distribution among placental mammals","volume":"281","author":"Wei","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000600_bib722","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1021\/acschembio.5b00070","article-title":"Covalent molecular probes for class A G protein-coupled receptors: advances and applications","volume":"10","author":"Weichert","year":"2015","journal-title":"ACS Chem Biol"},{"key":"10.1124\/pharmrev.122.000600_bib723","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1002\/chem.201904584","article-title":"Highly selective, amine-derived cannabinoid receptor 2 probes","volume":"26","author":"Westphal","year":"2020","journal-title":"Chemistry"},{"key":"10.1124\/pharmrev.122.000600_bib724","doi-asserted-by":"crossref","first-page":"173192","DOI":"10.1016\/j.pbb.2021.173192","article-title":"Untapped endocannabinoid pharmacological targets: pipe dream or pipeline?","volume":"206","author":"Wilkerson","year":"2021","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pharmrev.122.000600_bib726","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1124\/jpet.117.243808","article-title":"Investigation of diacylglycerol lipase alpha inhibition in the mouse lipopolysaccharide inflammatory pain model","volume":"363","author":"Wilkerson","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.122.000600_bib727","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1111\/bph.13469","article-title":"Diacylglycerol lipase \u03b2 inhibition reverses nociceptive behaviour in mouse models of inflammatory and neuropathic pain","volume":"173","author":"Wilkerson","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib728","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1021\/acs.jmedchem.8b00875","article-title":"Allosteric modulation of class A GPCRs: targets, agents, and emerging concepts","volume":"62","author":"Wold","year":"2019","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib729","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neuropharm.2017.06.015","article-title":"The cannabinoid system and pain","volume":"124","author":"Woodhams","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1124\/pharmrev.122.000600_bib730","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1124\/pr.112.007088","article-title":"Recent progress in prostaglandin F2\u03b1 ethanolamide (prostamide F2\u03b1) research and therapeutics","volume":"65","author":"Woodward","year":"2013","journal-title":"Pharmacol Rev"},{"key":"10.1124\/pharmrev.122.000600_bib731","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00782-2017","article-title":"Targeting fatty acid amide hydrolase as a therapeutic strategy for antitussive therapy","volume":"50","author":"Wortley","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1124\/pharmrev.122.000600_bib732","doi-asserted-by":"crossref","first-page":"8103","DOI":"10.2147\/IJN.S344318","article-title":"Endogenous oleoylethanolamide crystals-loaded lipid nanoparticles with enhanced hydrophobic drug loading capacity for efficient stroke therapy","volume":"16","author":"Wu","year":"2021","journal-title":"Int J Nanomedicine"},{"key":"10.1124\/pharmrev.122.000600_bib733","doi-asserted-by":"crossref","first-page":"817603","DOI":"10.3389\/fphar.2021.817603","article-title":"Genetic blockade of NAAA cell-specifically regulates fatty acid ethanolamides (FAEs) metabolism and inflammatory responses","volume":"12","author":"Xie","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib734","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cell.2020.01.007","article-title":"Cryo-EM structure of the human cannabinoid receptor CB2-Gi signaling complex","volume":"180","author":"Xing","year":"2020","journal-title":"Cell"},{"key":"10.1124\/pharmrev.122.000600_bib735","doi-asserted-by":"crossref","first-page":"34197","DOI":"10.1039\/D0RA05264G","article-title":"Liposomal N-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitor F96 as a new therapy for colitis","volume":"10","author":"Xiu","year":"2020","journal-title":"RSC Advances"},{"key":"10.1124\/pharmrev.122.000600_bib736","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1271\/bbb.70062","article-title":"Mammalian glycerophosphodiester phosphodiesterases","volume":"71","author":"Yanaka","year":"2007","journal-title":"Biosci Biotechnol Biochem"},{"key":"10.1124\/pharmrev.122.000600_bib737","doi-asserted-by":"crossref","first-page":"13565","DOI":"10.1038\/srep13565","article-title":"Potential analgesic effects of a novel N-acylethanolamine acid amidase inhibitor F96 through PPAR-\u03b1","volume":"5","author":"Yang","year":"2015","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.122.000600_bib738","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1021\/acs.jmedchem.8b02026","article-title":"Development of covalent ligands for G protein-coupled receptors: a case for the human adenosine A3 receptor","volume":"62","author":"Yang","year":"2019","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib739","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/s41589-022-01038-y","article-title":"Molecular mechanism of allosteric modulation for the cannabinoid receptor CB1","volume":"18","author":"Yang","year":"2022","journal-title":"Nat Chem Biol"},{"key":"10.1124\/pharmrev.122.000600_bib740","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1124\/jpet.108.145011","volume":"328","author":"Yao","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.122.000600_bib741","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/sj.bjp.0707568","article-title":"In vitro and in vivo characterization of A-796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain models","volume":"153","author":"Yao","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib742","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0083-6729(09)81002-9","article-title":"Organized trafficking of anandamide and related lipids","volume":"81","author":"Yates","year":"2009","journal-title":"Vitam Horm"},{"key":"10.1124\/pharmrev.122.000600_bib743","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1038\/s41598-021-83245-6","article-title":"Cholesterol as a modulator of cannabinoid receptor CB2 signaling","volume":"11","author":"Yeliseev","year":"2021","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.122.000600_bib744","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.biopsych.2021.03.023","article-title":"cAMP signaling-mediated phosphorylation of diacylglycerol lipase \u03b1 regulates interaction with ankyrin-G and dendritic spine morphology","volume":"90","author":"Yoon","year":"2021","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pharmrev.122.000600_bib745","doi-asserted-by":"crossref","first-page":"12748","DOI":"10.1074\/jbc.M114.559062","article-title":"Fatty acid-binding protein 5 (FABP5) regulates cognitive function both by decreasing anandamide levels and by activating the nuclear receptor peroxisome proliferator-activated receptor \u03b2\/\u03b4 (PPAR\u03b2\/\u03b4) in the brain","volume":"289","author":"Yu","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.122.000600_bib746","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1182\/blood.2020004871","article-title":"Signaling through the type 2 cannabinoid receptor regulates the severity of acute and chronic graft-versus-host disease","volume":"137","author":"Yuan","year":"2021","journal-title":"Blood"},{"key":"10.1124\/pharmrev.122.000600_bib747","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3390\/molecules27020453","article-title":"In silico prediction and validation of CB2 allosteric binding sites to aid the design of allosteric modulators","volume":"27","author":"Yuan","year":"2022","journal-title":"Molecules"},{"key":"10.1124\/pharmrev.122.000600_bib748","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41401-018-0037-3","article-title":"CB2 receptor antibody signal specificity: correlations with the use of partial CB2-knockout mice and anti-rat CB2 receptor antibodies","volume":"40","author":"Zhang","year":"2019","journal-title":"Acta Pharmacol Sin"},{"key":"10.1124\/pharmrev.122.000600_bib749","first-page":"246","article-title":"In vivo inflammation imaging using a CB2R-targeted near infrared fluorescent probe","volume":"5","author":"Zhang","year":"2015","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"10.1124\/pharmrev.122.000600_bib750","doi-asserted-by":"crossref","first-page":"10276","DOI":"10.1021\/acs.jmedchem.8b01467","article-title":"6-Benzhydryl-4-amino-quinolin-2-ones as potent cannabinoid type 1 (CB1) receptor inverse agonists and chemical modifications for peripheral selectivity","volume":"61","author":"Zhang","year":"2018","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000600_bib751","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/hipo.22344","article-title":"Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity","volume":"25","author":"Zhang","year":"2015","journal-title":"Hippocampus"},{"key":"10.1124\/pharmrev.122.000600_bib752","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.bbalip.2007.10.002","article-title":"Proteolytic activation and glycosylation of N-acylethanolamine-hydrolyzing acid amidase, a lysosomal enzyme involved in the endocannabinoid metabolism","volume":"1771","author":"Zhao","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pharmrev.122.000600_bib753","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.lfs.2012.06.039","article-title":"GPR55 and GPR35 and their relationship to cannabinoid and lysophospholipid receptors","volume":"92","author":"Zhao","year":"2013","journal-title":"Life Sci"},{"key":"10.1124\/pharmrev.122.000600_bib754","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1021\/acs.biochem.9b00625","article-title":"Identification of fatty acid binding protein 5 inhibitors through similarity-based screening","volume":"58","author":"Zhou","year":"2019","journal-title":"Biochemistry"},{"key":"10.1124\/pharmrev.122.000600_bib755","doi-asserted-by":"crossref","first-page":"104264","DOI":"10.1016\/j.phrs.2019.104264","article-title":"N-acylethanolamine acid amidase (NAAA) inhibitor F215 as a novel therapeutic agent for osteoarthritis","volume":"145","author":"Zhou","year":"2019","journal-title":"Pharmacol Res"},{"key":"10.1124\/pharmrev.122.000600_bib756","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.mcn.2016.08.011","article-title":"Regulated endosomal trafficking of Diacylglycerol lipase alpha (DAGL\u03b1) generates distinct cellular pools; implications for endocannabinoid signaling","volume":"76","author":"Zhou","year":"2016","journal-title":"Mol Cell Neurosci"},{"key":"10.1124\/pharmrev.122.000600_bib757","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1111\/bph.14997","article-title":"An evaluation of the anti-hyperalgesic effects of cannabidiolic acid-methyl ester in a preclinical model of peripheral neuropathic pain","volume":"177","author":"Zhu","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000600_bib758","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1016\/j.bmcl.2011.05.068","article-title":"Aryl 1,4-diazepane compounds as potent and selective CB2 agonists: optimization of drug-like properties and target independent parameters","volume":"21","author":"Zindell","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pharmrev.122.000600_bib759","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s00251-006-0138-x","article-title":"Formation of B and T cell subsets require the cannabinoid receptor CB2","volume":"58","author":"Ziring","year":"2006","journal-title":"Immunogenetics"},{"key":"10.1124\/pharmrev.122.000600_bib760","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000442679","article-title":"Therapy with a selective cannabinoid receptor type 2 agonist limits albuminuria and renal injury in mice with type 2 diabetic nephropathy","volume":"132","author":"Zoja","year":"2016","journal-title":"Nephron"},{"key":"10.1124\/pharmrev.122.000600_bib761","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/1529-0131(199801)41:1<163::AID-ART20>3.0.CO;2-9","article-title":"Dimethylheptyl-THC-11 oic acid: a nonpsychoactive antiinflammatory agent with a cannabinoid template structure","volume":"41","author":"Zurier","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1124\/pharmrev.122.000600_bib762","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/22761","article-title":"Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide","volume":"400","author":"Zygmunt","year":"1999","journal-title":"Nature"}],"updated-by":[{"DOI":"10.1124\/pharmrev.122.000600err","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000}}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724007853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724007853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/pharmrev.122.000600","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T12:47:02Z","timestamp":1740746822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699724007853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":745,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0031699724007853"],"URL":"https:\/\/doi.org\/10.1124\/pharmrev.122.000600","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/pharmrev.122.000600","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by The Author(s)","name":"copyright","label":"Copyright"}]}}